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SUMMARY
Suzuki coupling reactions of the bis(triflate) of alizarin afforded 1,2-
diarylanthraquinones. The reaction of the bis(triflate) with 1 equivalent of arylboronic acids 
proceeded with very good site-selectivity. The first attack occurred at carbon atom C-1 at the 
electronically more deficient position. Unsymmetrical 1,2-diarylanthraquinones were obtained 
by one-pot Suzuki coupling reactions with different arylboronic acids. The reactions were 
carried out by using Pd(PPh3)4 as a catalyst and K3PO4 as a base.
O
O
OTf
OTf
O
O
Ar
OTf
O
O
Ar
Ar
O
O
Ar1
Ar2
Ar1B(OH)2
Ar2B(OH)2
ArB(OH)2
ArB(OH)2
The reaction of the tris(triflate) of purpurin and 4 equivalents of arylboronic acids  
afforded 1,2,4-triarylanthraquinones. The reactions with 2 equivalents of arylboronic acids 
resulted in very good yields and proceeded with very good site-selectivity. The first attack 
occurred at carbon atom C-4 and the second one occurred at carbon atom C-1. 
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I also studied the synthesis of dimethyl 3,5-dihydroxyphthalate starting from the 
reaction of 1-methoxy-1,3-bis(trimethylsilyloxy)-1,3-diene with dimethyl 
acetylenedicarboxylate. The reaction of the bis(triflate) of the product with arylboronic acids 
gave arylated phthalates with very good site-selectivity in favour of carbon atom C-5.
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The reaction of 5,7-dibromo-8-hydroxyquinoline and triflic acid anhydride afforded the 
triflate in good yield. The reaction of the latter with 2 equivalents of arylboronic acids occurred 
at carbon atoms C-5 and C-7. The reaction with one equivalent of arylboronic acid occurred at 
carbon atom C-5. 
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1.1 Palladium Catalyzed Cross-Coupling Reactions
In organic chemistry, cross-coupling reactions of unsaturated (aryl, alkynyl, or alkenyl) 
carbon centers, catalyzed by transition metals, play a very important role. These types of 
reactions are becoming very important through their wide applications in organic synthesis, 
therefore organic chemists attach great importance particularly to study the organometallic 
mechanisms of these reactions.1 For example, the Wacker Process is an oxidation of ethylene to 
acetaldehyde using oxygen and palladium tetrachloride as catalyst;2 this  process is concerned 
as an important example for the use of palladium catalysts in the industry. In the last 30 years, 
palladium catalyzed cross-coupling reactions have been widely used to form carbon-carbon 
bond in organic synthesis. 
The reaction of organic halides (usually aryl/alkenyl halides) with olefins were 
developed by Heck and co-workers and is also called "Mizoroki-Heck reaction".3 Tsuji and 
Trost first reported the reaction of -allyl-(3-allyl)palladium cations with nucleophiles, it is 
also often referred to as "Trost Allylation or Tsuji-Trost Reaction".4 The cross-coupling 
reactions of organometallic reagents (such as organotin, organoboron and organozinc reagents) 
with organic halides were particularly developed by Kumada,5Stille,6 Suzuki.7 In 2010, the 
nobel prize was awarded jointly to Richard F. Heck, Ei-ichi Negishi and Akira Suzuki for the 
development of methods for palladium-catalyzed cross-couplings in organic synthesis. 
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1.2 Types of Palladium Catalyzed Cross-Coupling Reactions
There are many types including palladium catalyzed cross-coupling reactions. Some of 
them are mentioned here, but not exhaustively.
1.2.1 Buchwald-Hartwig Reaction
The Buchwald-Hartwig reaction is a palladium catalyzed cross-coupling reaction of aryl 
halides or pseudohalides (for example triflates) with primary or secondary amines as shown 
below in Scheme 1.1.8
Scheme 1.1 Buchwald-Hartwig reaction
NX RNH2
PdCl2(dppf )
NaOt-Bu
THF,
1.2.2 Fukuyama Reaction
The Fukuyama reaction is a palladium catalyzed reaction of organozinc compounds with 
thioesters to give ketones (Scheme 1.2).9
Scheme 1.2 Fukuyama reaction
O
R1 SEt R2ZnI
Pd-Cat
Toluene R
1
O
R2
1.2.3 Heck Reaction  
The Heck reaction (also called the Mizoroki-Heck reaction) is a reaction of aryl halides 
or vinyl halide with activated alkenes in the presence of base as well as using the palladium as 
catalyst (Scheme 1.3).10   
Scheme 1.3 Heck reaction
R1 X R2
Pd0
bsse
-HX
R1
R2
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1.2.4 Hiyama Coupling 
The Hiyama coupling is a palladium catalyzed coupling reaction between aryl, alkenyl, 
alkyl halides or pseudohalides and organosilanes. This reaction is similar to the Suzuki coupling 
reaction which needs the base or fluoride ion as an activating reagent (Scheme 1.4).11,12
  
Scheme 1.4 Hiyama coupling
R1 Si(R3)3 R2 R1 R2X
Pd-Cat
F or base
1.2.5 Kumada Reaction
The Kumada reaction is a cross-coupling reaction in organic chemistry between an alkyl
or aryl Grignard reagent and an aryl or vinyl halocarbon catalyzed by nickel or palladium
(Scheme 1.5).13
Scheme 1.5 Kumada reaction
R1 R2MgX
Pd-Cat
or Ni-Cat
X R1 R2
1.2.6 Negishi Reaction
The Negishi reaction is a reaction of various halides (aryl, vinyl, benzyl, or allyl) with 
organozinc compounds involving the nickel- or palladium catalyst. This reaction is used to 
synthesize unsymmetrical biaryls (Scheme 1.6).14,15
Scheme 1.6 Negishi reaction
R1 X R2ZnX R1 R2
PdCl2(PPh3)2
2(i-Bu)2AlH
1.2.7 Sonogashira Coupling 
The Sonogashira coupling is a reaction between terminal alkynes with aryl or vinyl 
halides. This reaction is performed with palladium catalysts, copper(I) as cocatalyst and an 
amine base (Scheme 1.7).16
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Scheme 1.7 Sonogashira coupling
R
PdCl2(Ph3P)2
CuI, R3N
RX
1.2.8 Stille Coupling 
The Stille coupling is a reaction of organotin compounds with organic halide including 
sp2-hybridized catalyzed by palladium (Scheme 1.8).17
Scheme 1.8 Stille coupling
R2 R1 R2X X Sn(R3)3
Pd-Cat
R1 Sn(R3)3
1.2.9 Tsuji-Trost Reaction 
The Tsuji-Trost reaction is a palladium-catalyzed allylation of nucleophiles such as 
active methylenes, enolates, amines and phenols, with allylic compounds such as allyl acetates 
and allyl bromides (Scheme 1.9).18
Scheme 1.9 Tsuji-Trost reaction
X Pd-Cat
NuH, base
Nu
1.3 Suzuki-Miyaura Cross-Coupling Reaction; A Brief History
The Suzuki-Miyaura cross-coupling reaction is an extremely versatile methodology for 
generation of carboncarbon bonds. This is a reaction of an aryl- or vinyl-boronic acid with an 
aryl-, vinyl- or an alkyl-halide catalyzed by palladium. It is widely used to synthesize poly-
olefins, styrenes and substituted biphenyls. The first published reaction was reported in 1979 by 
Akira Suzuki and co-workers. The reaction of alkyne 1 with borate 2 in benzene using 5 mol% 
of tetrakis(triphenylphosphine)palladium Pd(PPh3)4 gave (E)-1,2-diphenylethene (4) in 
reasonable yields (Scheme 1.10). This reaction was done in presence of base, such as sodium 
ethoxide in ethanol or sodium hydroxide in ethanol.19,20
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Scheme 1.10 The first example of a Suzuki coupling reaction 
ArBr
Pd(PPh3)4 (5 mol%)Ph
H
H
B
O
O
HB
O
O
Benzene, NaOH/EtOH
Ph
H
H
Ph
Ref lux, 4h
CPhHC
1 2 3 4(50%)
They also applied the same reaction in order to prepare (E,Z)-dienes. Although the 
reactions proceeded smoothly, the results were unsatisfactory because the initially formed (E,Z) 
isomer 7 was isomerized to the more stable (E,E) isomer 8 (Scheme 1.11).
Scheme 1.11 Synthesis of 7, 8
O
O
B
C6H13 EtO
Pd(PPh3)4 (1 mol%)H Br
C6H13 H
C6H13
C6H13
C6H13
C6H13
5 6 7(E,Z) (41%) 8(E,E) (47%)
A novel route for the synthesis of (E)-enyne 11 was also reported in the same paper 
(Scheme 1.12).
Scheme 1.12 A novel route for the synthesis of 11
Bu
H
H
B(Sia)2
Pd(PPh3)4 (1 mol%) Bu
CH
H
CPh
NaOMe, Benzene
Ref lux
9 10 11 (72%)
Ph Br
The reaction appears in almost all publications as the name of Suzuki-Miyaura        
cross- coupling reaction, but it is also often referred to as "Suzuki Coupling".
1.4 Reaction Mechanism
To identify more clearly how a Suzuki coupling reaction occurs, we should keep the 
following statement (Scheme 1.13) as an example19 of the coupling and follow the mechanism 
to understand the coupling how to occur. 
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Scheme 1.13 Suzuki coupling reaction of boronic ester and bromobenzene
O
O
B
n-Bu n-Bu
Br
Benzene/NaOEt
80 oC, 4h
12 13 17 (98%)
Pd(PPh3)4
1.4.1 Catalytic Cycle
The mechanism of the Suzuki coupling reaction is best viewed from the perspective of 
the palladium catalyst. The catalytic cycle of Suzuki coupling reaction involves three basic 
steps: Oxidative addition, Transmetallation and Reductive elimination.19,21,22 The catalytic cycle 
for the Suzuki coupling reaction is shown to be that depicted in Figure 1.1. The first step is the 
oxidative addition of palladium to the halide forming intermediate. Reaction with base gives 
intermediate 14, which via transmetalation with the boronate complex 12 forms the 
organopalladium species 16. Reductive elimination of the desired product 17 restores the 
original palladium catalyst.23
Figure 1.1 Catalytic cycle of Suzuki coupling reaction 
Pd0Ln
NaOEt
NaBr
Oxidative Addition
Transmetallation
PdIILn
Ph
Br
PdIILn
Ph
EtO
O
O
B
n-Bu
O
OB
EtO
PdIILn
Ph
n-Bu
n-Bu
Reductive Elimination
17
12
12a
13 Br
14
15
16
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The efficiency of palladium originates from its ability, when it is zerovalent, to activate 
C-X bonds (X=I, Cl, Br, O) by an oxidative addition which provides an organopalladium (II) 
complex prone to react with nucleophiles.24,25 A large variety of palladium(0) catalysts or 
precursors can be used for this reaction. Palladium(II) complexes along with a reducing agent
are also used.26
1.4.2 Oxidative Addition
The first step in Suzuki cross-coupling reaction is oxidative addition of palladium to the 
halide. Oxidative addition of 1-alkenyl, 1-alkynyl, allyl, benzyl and aryl halides to a Pd(0) 
complex gives a stable trans--palladium (II) complex (Scheme 1.14).2 The reaction proceeds 
with complete retention of stereochemistry for alkenyl halide and with inversion for allylic and 
benzylic halides. Oxidative addition is often the rate limiting step in the catalytic cycle. The 
relative reactivity decreases in the order of I > OTf > Br >> Cl. Aryl and 1-alkenyl halides,
activated by the proximity of electron-withdrawing groups, are more reactive to the oxidative 
addition than those containing donating groups, thus allowing the use of chlorides, such as 3-
chloroenones, for the cross-coupling reaction.
Scheme 1.14 Oxidative addition
Pd0LnBr Pd
Br
L
L
isomerization
Pd
L
L
Br
IIII
12 14 cis 14 tr ans
1.4.3 Transmetallation Processes 
Transmetallation step (Scheme 1.15) between organopalladium(II) complex and 
organoboron compound does not usually proceed in absence of base, due to low nucleophilicity 
of the organic group located at the boron atom.21 However the nucleophilicity can be enhanced 
by quarternization of the boron with negatively charged bases giving the corresponding “ate” 
complex.27 It is reported that such “ate” complexes undergo clean coupling reaction with 
organic halides.28
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Scheme 1.15 Transmetallation processes
Pd
L
L
Br
II
O
O
B
n-Bu O
O
BEtO
Pd
L
L
n-BuII
14
17 12a
16
O
BPhL2Pd
O
O
n-Bu
OEt
1.4.4 Reductive Elimination
Reductive elimination takes place directly from the cis-complex 16, and trans-complex 
16 reacts after its isomerization to the corresponding cis-complex (Scheme 1.16).21 Relative 
rates of reductive elimination from palladium(II) complexes are diaryl- > (alkyl)aryl- > diethyl-
> dimethylpalladium(II).
Scheme 1.16 Reductive elimination
Pd
L
L
n-BuII
Pd
L
L
n-BuII
16 tr ans 16 cis 17
n-Bu
Pd0Ln
1.5 Organoboron Compounds
For many decades, organic compounds containing boron have been attracted an 
increased attention.  Ever since, their chemical properties and their reactivity aspects had been 
studied. The discovery of hydroboration opened the door to organoboranes, which are 
represented among the most widely used reagents and intermediates in organic synthesis 
including asymmetric reactions. In addition, the previous studies on the chemistry of boron 
hydrides and carboranes conduce to new classes of compounds with unique structure and 
reactivity. In spite of this, the stability of organoboron compounds was not discovered until 
recently. In fact, the lists of organoboron compounds are increased nowadays. In addition to 
organoboranes,29 now it includes organoboronic acids and boronates,30 and more recently 
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organotrifluoroborates.31-33 As a result, these compounds mentioned hereinabove, have found 
their way to new and wide  applications. For example: molecular receptors, molecular sensors, 
novel materials, as well as biological probes and pharmaceuticals (Figure 1.2).33
Figure 1.2 Uses of organoboron compounds33. The picture was taken from Aust. J. Chem. 2007, 
60, 795-798.
1.5.1 Synthesis of Organoboron Reagents 
1.5.1.1 From Organolithium or Magnesium Reagents21  
Aryl- and l-alkenylboronic acids or their esters can be prepared by reaction of Grignard 
reagents or lithium reagents 18, 20 with trialkyl (Scheme 1.17).34
Scheme 1.17 Synthesis of organoboronic acids from Grignard reagents
ArMgx
B(OMe)3 ArB(OH)2
B(OMe)3
18 19
20 21
H
H
MgBr
H
H
H
B(OMe3)3
H
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In addition to that, a stereocontrolled synthesis of alkenylboronic acids and esters 
involves the reaction of a (Z)- or (E)-2-buten-2-ylmagnesium bromide with trimethylborate 
(Scheme 1.18).35
Scheme 1.18 Synthesis of organoboronic acid from trimethyl borate
H
Br
CH3
H3C Mg 1. B(OMe3)3
2. H3O H
B(OH)2
CH3
H3C
22 23
The disadvantages of application of these procedures include the contamination of small 
amount of the opposite stereoisomers, or bis-alkylation leading to the boronic acid derivatives 
and the formation of trialkylboranes.
Brown and co-workers reported the first synthesis of organolithium reagents 24 and 
triisopropyl borate, followed by acidification with HC1 to give directly alkyl-, aryl-, 1-alkynyl-, 
and 1-alkenylboronic esters 25 in high yields, over 90% (Scheme 1.19).36 Triisopropyl borate is 
shown to be the best of available alkyl borates to avoid such multiple alkylations of the borates.
Scheme 1.19 Synthesis of organoboronates from organolithium compounds
RLi B(OPr
i)3 R-B(OPri)3 R-B(OPri)2HCl
R= Alkyl, Aryl
24 24a 25
1.5.1.2 Hydroboration of Alkenes and Alkynes21
Suzuki and co-workers reported that the hydroboration of propargyl chloride and ethyl 
propiolate resulted terminal boron derivatives 27 with excellent regiochemistry, wheres the 
hydroboration with catecholborane or disiamylborane gives an inseparable mixture of internal 
and terminal boron adducts (Scheme 1.20).37
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Scheme 1.20 Hydroboration of alkynes with disiamylborane
1. HB(lpc)2
2. CH3CHO H
B(OEt)2
R
H
26 27
HR
The reaction of 2-(haloalkeny1)boronic esters 28 with KHB(OPri) or organolithium 
compounds proceeded with complete inversion of configuration at the sp2 carbon (Scheme 
1.21). The reaction is almost quantitative and highly selective (inversion >99%). Thus, the 
boron derivatives 29, 30 synthesized can be directly used for the following cross-coupling 
reaction without further purification.38-42
Scheme 1.21 Hydroboration of alkenes with KHB(OPri) or with organolithium compounds 
Br
B(OPri)2
n-Bu
H
1. KHB(OPri)3/Ether B(OPr
i)2
H
n-Bu
H
Br
B(OPri)2
n-Hex
H
n-BuLi/Ether B(OPri)2
n-Bu
n-Hex
H
2. H2O
3. HO(CH2)3OH
28 29 (87%)
-78 oC
28 30 (87%)
The other method is to prepare the stereospecifically (E)-l-alkenylboronates by 
alkylation of 31 with organozinc reagents in the presence of a palladium catalyst (Scheme 
1.22).43
Scheme 1.22 Alkylation of alkenes with organozinc reagents
I
B(OPri)2
C4H9
H
PhZnX, Pd(PPh3)4
Ph
B(OPri)2
C4H9
HTHF, 25 oC, 2h
31 32 (87%)
1.5.1.3 Haloboration of Terminal Alkynes21
The bromoboration of a terminal alkyne 33 gives -bromo-1-alkenylboronic esters 34, 
followed by palladium-catalyzed displacement of the -halogen with organozinc reagents which 
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proceeds strictly with retention of configuration.44,45 This reaction proceeds via a Markovnikov
addition which provides 2,2-diorgano-l-alkenylboronate 35 (Scheme 1.23).
Scheme 1.23 Bromoboration of terminal alkynes
1. BBr3
2. iPr2O
H
B(OPri)2
R1
Br
H
B(OPri)2
R1
Br
R2ZnX H
B(OPri)2
R1
R2
R1, R2= Alkyl, Aryl
33 34
33 35
HR1
While the addition of borontribromide of acetylene 36 itself results first a cis adduct
which then isomerizes to the trans adduct of (E)-l-alkenylborates 37 during its isolation
(Scheme 1.24).46,47
Scheme 1.24 Bromoboration of acetylenes
1. BBr3
2. iPr2O B(OPri)
H
Br
H
B(OPri)
H
Br
H R1ZnX
PdCl2(PPh3)2
H
B(OPri)
R2
H
37 38
36 37
HH
1.5.1.4 Cross-Coupling Reactions48
Miyaura and co-workers were reported the first cross-coupling reactions of aryl halides
40, 42 with the pinacol ester of diboronate 39 (Scheme 1.25).49  KOAc was selected to be a 
more suitable base for borylation of aryl iodides,50 bromides,51 chlorides49a and triflates.52,53
PdCl2(dppf) is better than Pd(PPh3)4 because palladium-triphenylphosphine complexes often 
resulted in formation of byproducts derived from coupling of the diboron with a phenyl group 
on triphenylphosphine in the reaction of electron-rich aryl halides.49a
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Scheme 1.25 Synthesis of organoboronates by cross-coupling reactions
BrB B
O
O
O
O
PdCl2(dppf)2
KOAc, DMSO, 24 h
80 oC
B
O
O
ClB B
O
O
O
O
Pd(dba)2/2PCy3
KOAc, Dioxane, 4 h
80 oC
B
O
O
NO2 NO2
39 40 41 (69%)
39 42 43 (88%)
OMe OMe
After the first preparation of organoboronic esters, a lot of publications appeared related 
to synthesis of organoboronic esters by using cross-coupling reactions of aryl halides.54-57
1.5.1.5 Diboration, Silylboration, and Stannylboration48
Addition reaction of various element-element bonds (B-B, B-Si and B-Sn) to alkenes 
and alkynes provides polymetallic organic compounds (Scheme 1.26).58 Suzuki and co-workers 
published the first addition reaction of the pinacol ester of diboronate 39 to alkynes 44 using 
Pt(PPh3)4 as catalyst and DMF as solvent.
Scheme 1.26 Addition of various diboronates bonds to alkynes
C C B B
O
O
O
O
Pt(PPh3)4
DMF, 80 oC B BO
O
O
O
44 39 45 (79%)
They proposed a catalytic cycle for the diboration of alkynes, which involves the 
oxidative addition of the B-B bond to the platinum(0) complex, the stereospecific insertion of 
alkyne to the B-Pt bond, and finally the reductive elimination of the bis(bory1)- alkene as 
outlined in Figure 1.3.
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Figure 1.3 Catalytic cycle for the diboration of alkynes
Pt(0)
Pt BB
Ph Ph
B Pt
O
O
B
O
O
C C
B B
O
O
O
OB BO
O
O
O
44
45
39
39a
44a
In addition to this reaction, many applications were applied to synthesize boronic acids 
and esters by using these methods.59  
1.5.1.6 Olefin Metathesis48
Renaud and co-workers reported the synthesis of cyclic 1-alkenylboronic esters 47, 50
from organoboronic esters 46, 49 at room temperature by using Grubbs’ alkylidene-ruthenium 
complexes (Scheme 1.27).60 Many cyclic alkenylboronic esters have been obtained by using 
these methods.61-63
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Scheme 1.27 Synthesis of organoboronates by olefin metathesis 
N
Boc
B
O
O
Ru
PCy3
PCy3
Ph2Cl
Cl
Benzene, r.t, 95 h
NBoc B
O
O
OMe
H
1. LDA, THF, -78 oC
2. EtOBpin
3. HCl, Et2O
OMe
B
O O
Cl2(PCy3)2Ru=CHPh
Benzene, r.t
B
O O
46 47 (84%)
48 49 50 (70%)
OMe
1.5.1.7 Aromatic C-H Borylation48
Organoboron compounds can be obtained by direct borylation of hydrocarbons.58 The 
first metal-catalyzed reaction of a borane 52 and an arene 51 was reported by Smith and co-
workers (Scheme 1.28).64 The reaction was performed by using pre-catalyst 1
Cp*Ir(PMe3)(H)(BPin) ( 	 5-C5Me5) and pre-catalyst 2 
4-C6Me6).64 Many 
reactions have been studied using various catalysts.65-68
Scheme 1.28 Synthesis of organoboronates by borylation of hydrocarbons
H B
O
O
H
Pre-catalyst 1
B
O
O150 oC, 120 h
H B
O
O
H
Pre-catalyst 2
B
O
O150 oC, 2.5 h
51 52 53 (53%)
51 52 53 (92%)
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1.5.1.8 Miscellaneous Methods48
The reaction of Grignard or lithium reagents with boron halides or borates was used for 
the preparation of 2-formylbezenboronic acid (55) in 57 % yield (Scheme 1.29).69
Scheme 1.29 Synthesis of organoboron compounds by lithium reagent
Br
CHO
1. OHCH2CH2OH
2. n-BuLi
3. B(OR)3
4. H3O
B(OH)2
CHO
54 55
The reaction between borane and arylmetallic derivatives leads to arylboronic acids, but 
in low yields (9-60%). This is due to the formation of other organoborane derivatives. 
Aryltrialkyltin compound 56 reacts with borane 57 in THF to give mixtures of trialkyltin 
hydrides 56a and arylboranes 57a, which on hydrolysis give the arylboronic acid 58 in high 
yields (Scheme 1.30).70
Scheme 1.30 The reaction between borane and arylmetallic derivatives
R3SnAr BH3
THF R3SnH ArBH2 ArB(OH)2
H2O
56 57 56a 57a 58
1.5.2 The Advantage of Organboron Compounds
There are many advantages that Organoboron derivatives provide over other 
organometallic derivatives.71,72 They can tolerate a broad range of functional groups, such as 
organic halides, carbonyl, etc. The electronegativity of boron is about 2.0 which is close to the 
value of carbon of 2.5 and is higher than the electronegativities of lithium, magnesium, or most 
of the transition metals which range from 0.86 to 1.75. Therefore the boronic compounds are 
air-stable and also water tolerant. The starting materials and borate by-products are not toxic. 
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1.6 Reaction Conditions
1.6.1 The Catalyst
The most commonly used system is Pd(PPh3)4, but other palladium sources have been 
used including PdII pre-catalysts that are reduced to the active Pd0 in situ.73
-Pd2(dba)3 + PPh3                                      59
-Pd(OAc)2 + PPh3                                      60
-PdCl2(dppf) (for sp3-sp2 couplings)         61
In addition to that, N-heterocyclic carbenes are also used as an alternative to phosphine 
ligands. The nucleophilic N-heterocyclic carbene 62 is the active ligand and is formed in situ 
from 63 (Figure 1.4).74
Figure 1.4 N-heterocyclic carbene ligands 62, 63
N N
..
CH3
CH3
H3C
H3C
H3C
CH3
N N
CH3
CH3
H3C
H3C
H3C
CH3Cl
-
62 63
1.6.1.1 Tetrakis(triphenylphosphine)palladium(0) Pd(PPh3)4
This compound has the molecular formula Pd[P(C6H5)3]4, it is light-sensitive, unstable 
in air, and a coordinatively saturated Pd(0) complex. Sometimes, Pd(PPh3)4 is less active as a 
catalyst, because it is overligated and has too many ligands to allow the coordination of some 
reactants.75
Malatesta and co-workers prepared the catalyst by reduction of chloropalladate 65 with 
hydrazine 66 in the presence of the phosphine (Scheme 1.31).76
Background and Introduction 
Page | 19
Scheme 1.31 Synthesis of 67
PdCl2
2 PPh3 cis-PdCl2(PPh3)2
cis-PdCl2(PPh3)2
2 PPh32.5 N2H4 Pd(PPh3)4 0.5 N2 2 N2H5+Cl-
64 65
65 66 67
The reaction is proceeding in one pot without isolation and purification of cis-
PdCl2(PPh3)2 intermediate 64.77 Pd(PPh3)4 is widely used as a catalyst for palladium-catalyzed 
coupling reactions. Most applications include the Heck reaction and Suzuki-Miyaura coupling
reaction.
1.6.2 Effect of Base and Water 
The synthesis of trityl losartan 70 was studied by Smith and co-workers (Scheme 1.32). 
The product belongs to a new class of drugs (angiotensin II receptor antagonists) and was 
developed for the treatment of high blood pressure and heart failure.78
Scheme 1.32 Synthesis of 70
N
N
Br
HOH2C n-Bu
Cl
N
NN
N
Tr
(HO)2B
Pd(PPh3)4
K2CO3, H2O
DME N N
N
N
Tr
N
Nn-Bu
CH2OH
Cl
Tr= triphenyl methyl
68 69 70 (75%)
They indicated that the Suzuki coupling reaction was efficient when the pKa of base was 
close to 10, whereas it failed when the base was a bicarbonate (pKa close to 6). Considering the 
pKa of phenylboronic acid 8.8, phenylboronic acid was transformed into 
trihydroxyphenylborate (PhB-(OH)3), showing a pH higher than 9. The authors supposed that 
this anion was the reactive species rather than the neutral boronic acid. Kinetic studies also 
proved that water and base are required to activate the boronic acid. They assumed that one mol
of water and one mol of carbonate are required initially to activate the boronic acid and then to 
neutralize the produced boric acid.
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1.6.3 Effect of Solvent
The Suzuki coupling reaction is unrivaled among metal-catalyzed cross-coupling 
reactions in that it can be run in biphasic (organic/aqueous) or aqueous environments in 
addition to organic solvents.79
1.6.4 Microwave-Assisted Reactions48
In 1996, Hallberg and co-workers reported the first application of microwaves to rapid 
carbon-carbon bond formation (Scheme 1.33).80 They confirmed that many metal-catalyzed 
reactions are completed within a few minutes and full conversion can be achieved in a few 
minutes. The reactions were carried out in water, ethylene glycol, or DMF, due to the ability of 
polar solvents to efficiently absorb microwaves irradiation. 
Scheme 1.33 Microwave-assisted Suzuki coupling reactions    
H3C Br
2.8 min 55w
Pd(PPh3)4, EtOH
DME. H2O
H3C
O
NHRAM
Br
1. ArB(OH)2
3.8 min. 45 W
O
H2N
71 72 (55%)
ArB(OH)2
73 74 (97%)
Pd(PPh3)4, EtOH
2M Na2CO3, DME. H2O
2.TFA
1.6.5 Coupling Reactions of [RBF3]K48
Potassium organotrifluoroborate salts are easily prepared81 and purified, and thus they 
are easier to handle compared to the preparation of the corresponding boronic acids. Potassium 
organotrifluoroborate salts are obtained by treatment of boronic acids with KHF2.82 Potassium 
salts are generally insoluble in common organic solvents and require polar solvents such as 
MeCN and H2O at high temperatures. Coupling reactions of organotrifluoroborates have several 
advantages including the simplicity of the preparation of pure and stable crystalline material 
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compared to the preparation of the corresponding boronic acids. Cross-coupling of arylboronate 
75 and alkyl derivatives 78 with organic halides 76, 79 in the presence of bases resulted in 
successful coupling (Scheme 1.34).82,83
Scheme 1.34 Coupling reactions of [RBF3]K
Br CHO
Pd(OAc)2 (5 mol%)
dppb (5 mol%)
CHOBF3K- n-BuN4+
75 76 77 (90%)
CH3(CH2)7BF3K
TfO CN (CH2)7CH3NCPdCl2(dppf).CH2Cl2
Cs2CO3, THF/H2O
Reflux, 18 h
78 79 80 (65%)
Cs2CO3, DME/H2O (1:1)
r.t.-50 oC, 12-24 h
1.7 Site-Selective Suzuki-Miyaura Cross-Coupling Reactions
Recently, site-selective Suzuki coupling reactions became important. Complex 
compounds can be prepared by successive coupling reactions of substrates containing one, two 
or more possible reactive sites. The first attack usually occurs at the more electron deficient and 
less sterically hindered postion.84,85
Gronowitz and co-workers were able to convert 2,4-dibromofuran (81) into the 4-
bromofuran (82) in high yield (Scheme 1.35). The electronic difference of the two positions 
resulted a higher yield and better selectivity as compared to 2,5-dibromofuran.86
Scheme 1.35 Site-selective reaction of 81
O Br
Br
N
N
OtBu
OtBu
(HO)2B
O
Br
N
N
BuOt
OtBu
Pd(PPh3)4
NaHCO3, DME
81 82 (86%)
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The reaction of 2,3-dibromobenzofuran (83) with one equivalent of boronic acids
resulted in site-selective formation of 2-aryl-3-bromobenzofurans. The 2-position is less 
electron rich compared to the 3-position (Figure 1.5).87
Figure 1.5 Possible explanation for the site-selectivity of 83
O
Br
Br
less electron rich
more electron rich
83
Further studies towards site-selective Suzuki coupling reactions of imidazoles have been 
confirmed by Ohta and co-workers. Carbon atom C-2 is attacked first and then the second 
attack occurred at carbon atom C-5 (Scheme 1.36).88 Revesz and co-workers used similar 
Suzuki coupling reactions in order to synthesize potential kinase inhibitors and anti-
inflammatory drugs.89
Scheme 1.36 Site-selective reaction of 84
N
NBr
Br
Br
MOM
PhB(OH)2
Pd(PPh3)4, Na2CO3
N
NBr
Br
Ph
MOM
N
NBr
Ph
MOM
B(OH)2
OMe MeO
N
NBr
Br
Ph
MOM
PhH/MeOH/H2O
Pd(PPh3)4, Na2CO3
PhH/MeOH/H2O
84 85 (94%)
85 86 (71%)
Iwao and co-workers carried out the Suzuki coupling reaction of pyrroles containing 
two methoxycarbonyl groups at carbon atoms C-2 and C-5 (Scheme 1.37).90 The first attack 
occurred at carbon atom C-3 which can be explained by steric reasons. A further cross-coupling 
at C-4 is not preferred, due to the large aryl substituent present at carbon atom C-3.
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Scheme 1.37 Site-selective reaction of 87
N
TfO OTf
MeO2C CO2Me
OMe
OMe
MeO
MeO B(OH)2
Pd(PPh3)4, aq.Na2CO3
THF, Reflux 4h
N
OTf
MeO2C CO2Me
OMe
OMe
MeO
MeO
3
87 88 (78%)
The first attack of N-(TBDMS)-2,6-dibromoindole occurred at carbon atom C-6 
(Scheme 1.38). Several boronic acids were used, providing the 6-substituted products in 52-
78% yield.88
Scheme 1.38 Site-selective reaction of 89
N
TBS
Br
Br
S
B(OH)2
Pd(PPh3)4, Na2CO3
PhH/MeOH/H2O
N
TBS
Br
S
89 90 (61%)
Langer and co-workers showed that the site-selective Suzuki coupling reaction of indole 
91 was found to be in favour of the 2-position (Figure 1.6). This is due to the fact that the 
electronic character of C-2 and C-3 appears to be sufficiently different because site-selective 
transformations are observed.91
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Figure 1.6 Possible explanation for the site-selectivity of 91
N
Br
Br
more electron-def icient
less electron-deficient
strong electronic dif ference
high site-selectivity
91
In addition, the substrates 2,3,4-tribromothiophene (92) and 2,3,5-tribromothiophene
(93) showed very good site selectivity. For the 92 the first coupling occurred at the carbon atom 
C-2 then the second coupling took place at carbon atom C-4. In case of 93 the first coupling 
preferred to be at carbon atom C-5 and the second at carbon atom C-2 (Figure 1.7). The 
selectivity can be explained based on the different electronic and steric properties of the three 
different C–Br bonds of 92 and 93 (Figure 1.7).92
Figure 1.7 Possible explanation for the site-selectivity of 92, 93
S
Br
Br
electron-deficient
sterically hindered
Br
S
Br
BrBr
electron-deficient
not sterically hindered
less electron-deficient
not sterically hindered
most electron-deficient
less sterically hindered
less electron-def icient
less sterically hindered
less electron-def icient
most sterically hindered
92 93
Guglielmetti and co-workers reported the site-selective Suzuki coupling reaction of 2,3-
dibromobenzothiophene (94) (Scheme 1.39). They proved that the site-selective attack occurred 
at position 2 of the 2,3-dibromobenzothiophene (94). This reaction was used to synthesize 2,3-
diarylbenzo[b]thiophenes 95 and 97 substituted by two different aryl rings.93
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Scheme 1.39 Site-selective reaction of 94
S
Br
Br
S
R1
R1
R2
R2
97a R1= Me, R2= OMe (71%)
97b R2= Me, R2= OMe (58%)
S
Br R1
R1
96a R1= Me
96b R1= OMe
95a R1= Me (74%)
95b R1= OMe (65%)
Ar(OH)2
Pd(PPh3)4
aq. Na2CO3
DME/EtOH
Reflux, 3d
Ar(OH)2, Pd(PPh3)4
Ba(OH)2, DME/H2O
Ref lux, 3d or 4d
Ar(OH)2, Pd(PPh3)4
Ba(OH)2, DME/H2O
Ref lux, 3d or 4d
94
S
R1
R1
R2
R2
Corte and co-workers revealed that the site-selective Suzuki coupling reaction can 
depend on the type of catalyst in the reaction of 2,6-dichloropyridines (98) with boronic acids. 
The substrate reacted with distinct selectivity for 6-position using Pd(PPh3)4 as catalyst. On the 
other hand, in case of using the pre-catalyst PXPd2 (Pd2Cl4(PtBu2Cl)2) or PdCl2(dppf) 
preferentially the 2-substituted product 101 was obtained (Scheme 1.40). It was disputed that a 
chelation is responsible for the observed effect and that the chelation might be enhanced if 
coordinatively unsaturated Pd(0) intermediates are generated.94
Scheme 1.40 Site-selective reaction of 98
NCl Cl
O
OMe
NPh Cl
O
OMe
NCl Cl
O
NHR
NCl Ph
O
OMe
R= CH2CH2OPh
K2CO3 , THF
PhB(OH)2 ,Pd(PPh3)4
PhB(OH)2, PXPd2
K2CO3, THF
98 99
100 101 (61%)
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In order to synthesize the qindoline 105, Timari and co-workers studied a regioselective 
coupling reaction of 2,3-dibromoquinoline (102) with boronic acid taking into consideration the 
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halogen atom (Scheme 1.41).95
Scheme 1.41 Synthesis of 105
N Br
Br
B(OH)2
NHpiv
N
Br
NHpiv
N
Br
NH2
H+/H2O
pyridinium-hydrochlorideN
H
N
Pd(PPh3)4, aq. Na2CO3
DME, Reflux, 6h
102 103 (54%)
105 104
Woodward and co-workers showed that the site-selective Suzuki coupling reaction of 
1,3-dichloroisoquinoline (106) with boronic acids took place at the 1-position to give 107
(Scheme 1.42).96 These reactions were done by using Pd(PPh3)4 as a catalyst in the presence of 
CsF as a base. The carbon atom C-1 is more reactive than carbon atom C-3, due to the ease of 
oxidative addition at this electrophilic position.
Scheme 1.42 Site-selective reaction of 106
N
Cl
Cl
B(OH)2OMe
N
Cl
OMe
106 107 (80%)
Pd(PPh3)4, DME
CsF, Ref lux, 6h
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The Site-selective Suzuki coupling reaction of 2,4-dichloropyrimidine (108) with 2-
thienylboronic acid (109) was confirmed by Gronowitz and co-workers (Scheme 1.43).97 They 
proved that the 4-position 110 is more reactive than the 2-position.98
Scheme 1.43 Site-selective reaction of 108
N
N Cl
Cl
S B(OH)2 N
N Cl
S
Pd(PPh3)4, aq.Na2CO3
DME, Reflux
108 109 110
For the reaction of 2,4`-bis(trifluoromethylsulfonyloxy)diphenylsulphone (111) with 
boronic acid derivatives, the Suzuki coupling reactions occurred at carbon atom C-4´ 112
(Scheme 1.44).99 The oxidative addition of palladium usually occurs first at the most electron-
deficient carbon atom. Carbon atoms C-2 and C-4`of the bis(triflate) are expected to be equally 
electron deficient. The site-selective formation of 112 can be explained by the fact that the 
carbon atom C-4´ is less sterically hindered.
Scheme 1.44 Site-selective reaction of 111
S
O
O
OTf
OTf
B(OH)2
Pd(PPh3)4, K3PO4
Dioxane, 110 oC, 4h
S
O
O
OTf
OMe
MeO
111 112 (76%)
Site-selective reactions of both chloro and fluoro-dihydoxyphthalate derivatives 113, 
114 were also studied by Langer and co-workers. For both derivatives, the site-selective attack 
took place at C-5 and the formation of the opposite regioisomers was not observed (Scheme 
1.45). The site-selectivity can be explained by steric reasons.100
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Scheme 1.45 Site-selective reaction of 113, 114
CO2Me
CO2Me
OTf
TfO
X CO2Me
CO2Me
OTf
Ar
XB(OH)2R
Pd(PPh3)4, K3PO4
Dioxane, 90 oC, 8h
113 X= F
114 X, Cl
113a X=F, R= 4-CF3 (68%)
114a X=Cl, R= 4-CF3 (63%)
The reaction of the 3,4-bis(triflate) of benzophenone 115 with boronic acid derivatives 
provided very good site selectivity.101 The first attack occurred at C-4 which is located para to 
the keto group (Figure 1.8). Carbon C-4 is more electron deficient than C-3 which is located 
meta to the keto group. Steric parameters have presumably no effect, due to the similar steric 
environment of carbon atoms C-4 and C-3. 
Figure 1.8 Possible explanation for the site-selectivity of 115
O
OTf
OTf
more electron-deficient
less electron-deficient
115
The attack of boronic acids in site-selective Suzuki coupling reactions of the bis(triflate) 
of phenyl 1,4-dihydroxynaphthoate 116 occurred at the sterically more hindered position C-1
(Figure 1.9). This was confirmed by Langer and co-worker.102 The reactions are an example of 
site-selectivity controlled by electronic parameters. 
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Figure 1.9 Possible explanation for the site-selectivity of 116
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OTf
OTf
O
OPh
5
2
OTf
OTf
O
OPh
carbon C-1
more sterically hindered
more electron deficient
carbon C-1
less sterically hindered
less electron def icient
carbon C-2
more sterically hindered
carbon C-5
less sterically hindered
116 116a
1.8 Applications of Suzuki-Miyaura Cross-Coupling Reactions
Since the Suzuki coupling reaction was discovered by Akira Suzuki and Norio Miyaura 
it found multiple applications in many areas including total synthesis, pharmaceutics as well 
polymer chemistry. 
1.8.1 Total Synthesis
In 1981, Rossi and co-workers reported the first total synthesis of (E)-9,11-dodecadien-
1-yl acetate 119 which an insect sex pheromone isolated from Diparopsis castanet (Scheme 
1.46).103 The key step in this elegant strategy was the Suzuki coupling reaction. It was prepared 
using the reaction between vinyl borane (E)-120 118 and vinyl bromide 117, followed by 
treatment of the resulting crude product mixture with acetic anhydride in acetic acid in order to 
convert the tetrahydropyranyl protecting group into the corresponding acetate.
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Scheme 1.46 Total synthesis of 119
Br OTHP
B
Me
Me
Me
Pd(PPh3)4 (1 mol%)
NaOH, THF/H2O, 50 oC
Ac2O/AcOH, 80 oC
O
O
Me
117 118
119 (54%)
The Palytoxin 120 (Figure 1.10) an extremely poisonous, water-soluble substance from 
marine coelenterates belonging to the genus Palythoa,104 was originally isolated in 1971 in 
Hawaii from the seaweed-like coral. Palytoxin is a complex marine natural product containing 
71 asymmetric centers, cleaved into several compounds by sodium periodate. Kishi and co-
workers first synthesized palytoxin in 1994.105
Figure 1.10 Structure of (120).104b The picture was taken from Angew. Chem. Int. Ed. 2005, 44,
4442-4489.
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They concluded that the use of TlOH instead of KOH has many advantages. This 
method can be used in the presence of fragile functional groups as well as with large molecular 
weights in addition to formation of byproducts is nonexistent (Scheme 1.47).106
Scheme 1.47 Total synthesis of 120
ZO
ZO
B(OH)2
OZ
OZ
I
O
OY
YO OY
OX
MeO
Pd(PPh3)4
TIOH, rt. 30 min
ZO
ZO
OZ
OZ
O
OMe
YO OY
OY
OX
X= Ac, Y= Z= Si(Me)2(t-Bu)
121 122 123 (94%)
THF
FR182877 124 (Figure 1.11) is an antibiotic isolated from the fermentation broth of 
Streptomyces sp. No. 9885, in 1998.107 FR182877 exhibited potent antitumor activities against 
murine ascitic tumor and solid tumor in vivo.
Figure 1.11 Structure of 124
124
O
O
H
H
H
H
H
H
OH
HO
H3C
CH3
CH3
CH3
O
Evans and Starr used the Suzuki coupling reaction between 125 and 126 to prepare 
regioselective product 127.108 They optimized this reaction by using TI2CO3 as a base which 
gave an excellent yield (84%) (Scheme 1.48).
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Scheme 1.48 Synthesis of 127
TBDPSO
(HO)2B
OTBS
OTBS
Me
N
MeO
Me
O
Me
OTBS
Me Br
Br
Pd(PPH3)4 (5 mol%)
TI2CO3, THF/H2O, 23 oC
Intermolecular
Suzuki Coupling
TBDPSO
OTBS
OTBS
Me
N
MeO
Me
O
Me
OTBS
Me Br
127 (84%)
125 126
And finally, they utilized the Suzuki methylation in order to convert 128 to 129. They 
used TMB as a methylating agent.109 Saponification of the ethyl ester (TMSOK, THF)110 and 
lactonization (1-methyl-2-chloropyridinium iodide, NaHCO3, 62%, 2 steps)111 afforded 
FR182877 (Scheme 1.49).
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Scheme 1.49 Total synthesis of 124
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Sugano and co-workers were isolated phomactin A 133, in the early 1990s.112 The 
phomactins show biological activity as platelet activating factor (PAF) antagonists. Halcomb 
and co-workers constructed the phomactin A 133 by using a regioselective hydroboration on 
the terminal olefin of 130 with 9-BBN to give an intermediate alkyl borane 131, which cyclized 
using a modification of Johnson’s conditions (Scheme 1.50).113 The Suzuki coupling reaction 
proceeded with the sensitive dihydrofuran ring in place. Treatment with TBAF then hydrolyzed 
both silyl groups to give phomactin A 133.
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Scheme 1.50 Total synthesis of 133
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Danishefsky and Trauner synthesized (+)-Halichlorine114 137, a marine alkaloid recently 
isolated from the sponge Halichondria okadai.115 Hydroboration of the protected amino alkene 
134, followed by palladium-mediated Suzuki coupling reaction with methyl (Z)-3-iodoacrylate, 
afforded the -unsaturated ester 135 (Scheme 1.51). Upon deprotection of the amino function 
with TFA and subsequent basification, 135 underwent a highly stereoselective intramolecular 
1,4-addition to afford piperidine 136 as the only isolated isomer. Intermediate 136 was 
subsequently converted into the inhibitor (+)-halichlorine 137 in eight steps.
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Scheme 1.51 Total synthesis of 137
TBDPSO
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134 135
137 136 (77%)
Kündig and co-workers prepared vertine 142 in eleven steps including Suzuki coupling
reaction and ring-closing metathesis.116 Vertine is classified as a member of the Lythraceae 
alkaloids isolated in 1962 by Ferris from Decodon verticillatus (L.) Ell.117 The reaction between 
138 and 139 afforded the product 140 which was isolated as a mixture of two apparent 
atropisomers in a ratio of 3:1 (Scheme 1.52). To overcome the problem the best choice was 
choosing L-Selectride as a reducing agent118 to yield a single diastereomer in 62% yield. 
Aldehyde 141 was obtained by oxidation with MnO2 in 98% yield.
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Scheme 1.52 Total synthesis of 142
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Fostriecin 146 is a pyranone-containing natural product isolated from Steptomyces  
pulveraceus.119 Fostriecin has been shown to possess significant in vitro cytotoxic activity 
against a broad range of cell lines,120 such as leukemia, lung cancer, breast cancer, and ovarian 
cancer and also antitumor activity against leukemia in vivo.121 O’Doherty and Gao have been 
recently prepared the Fostriecin in 24 steps starting from enyne.122 The reaction of vinyl 
boronate 143 and vinyl iodide 144 led to (Z,Z,E)-triene 145 with excellent alkene 
stereoselectivity (>20:1) and 80% yield. The reaction has been achieved by using 20% Pd/PPh3
system (20% Pd2(dba)3·CHCl3/ 80% PPh3) instead of using the Pd(PPh3)4/Ag2O system which 
led to no reaction (Scheme 1.53). 
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Scheme 1.53 Total synthesis of 146
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Diazonamide A 147 was isolated from the colonial ascidian Diazona chinensis (Figure 
1.12).123 Diazonamide A possesses potent in vitro activity against HCT-116 human colon 
carcinoma and B-16 marine melanoma cancer-cell lines.124 Nicolaou and co-workers reported 
the synthesis of diazonamide A 147 by using also Suzuki coupling reaction.125,126
Figure 1.12 Structures of 147
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1.8.2 Synthesis of Pharmaceuticals
E2040 151 is a potent antagonist of D3/D2/5-HT2 receptors being developed for the 
treatment and amelioration of mental disorders such as aggressive behavior, senile dementia, 
mental excitation, poriomania, delirium, hallucination, hyperkinesias, schizophrenia, emotional 
disturbance, depression, neurosis, psychophysiologic disorder and anxiety.127 The intermediate 
150 was synthesized by Urawa and co-workers at Eisai Co. in Japan.128 This reaction was 
achieved by the Suzuki coupling reaction of optically active 148 with boronate 149 (Scheme 
1.54).
Scheme 1.54 Synthesis of 151
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They proposed mechanism for the Suzuki coupling reaction is shown below in Figure 
1.13. 
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Figure 1.13 Catalytic cycle for the synthesis of 151
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Larsen and co-workers synthesized the angiotensin II receptor antagonist Losartan 155
which is used mainly to treat high blood pressure (hypertension).129 The coupling between 
bromide 152 and boronic acid 153 is catalyzed by a palladium(0) catalyst in the presence of a 
base at 80 oC (Scheme 1.55).
Scheme 1.55 Synthesis of 155
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The potent cathepsin K inhibitor 158 is used to treat osteoporosis. O’Shea and co-
workers reported the synthesis of it by application of the Suzuki coupling reaction.130 They 
optimized the conditions of this coupling and found that the best conditions involve the use of 3 
mol% PdCl2(dppf).CH2Cl2 as a catalyst with aqueous K2CO3 as a base in 10:1 Toluene/DMF at 
80 °C. Under these conditions, the reaction was complete within 2 h to yield 158 in 89%
(Scheme 1.56).
Scheme 1.56 Synthesis of 158
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A useful application of the Suzuki coupling reaction is the synthesis of 2-amino-tetralin 
161 which is a pharmaceutical ingredient that is useful in the treatment of epilepsy, stroke, and 
brain or spinal trauma.131 Coupling of arylbromide 159 with boronic acid 160, in the presence 
of K2CO3 (Scheme 1.57) and PS–Pd 162 as a catalyst (Figure 1.14).
Scheme 1.57 Synthesis of 161
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Figure 1.14 Structure of 162   
Pd
Pd
162 PS
1.8.3 Polymer Synthesis
1.8.3.1 Suzuki Poly-Condensation (SPC)
We can simply identify the Suzuki poly-condensation as a step-growth polymerization 
of bifunctional aromatic monomers of poly(arylene)s and related polymers.132 The required 
functional groups, boronic acid or esters on the one side and bromide or iodide, on the other, 
may be present in different monomers (AA/BB approach) or combined in the same monomer 
(AB approach). Most polymers prepared by this method are poly(paraphenylene)s, which are 
one of the most important classes of conjugated polymers.132,133
Conjugated polymers have been identified as a fascinating class of novel conductors and 
semiconductors that have the electrical and optical properties of metals and semiconductors 
and, in addition, have the processing advantages and mechanical properties of molecular 
materials. The monomers of types AA and BB are widely used in Suzuki polycondensation. 
Among the most commonly used monomers of BB type is 2,5-dialkyl-1,4-benzene-bis(boronic) 
acid.134,135 The reaction conditions are like the ones Suzuki reported in his famous original 
article of 1981.21,26,136 The mechanism of SPC is supposed to involve the same steps of 
oxidative addition, transmetallation, and reductive elimination as for Suzuki cross-coupling. 
The standard catalyst precursor is Pd(PPh3)4.
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Scheme 1.58 Suzuki poly-condensation (SPC).133b The picture was taken from Macromol. 
Rapid Commun. 2009, 30, 653-687.
Schlüter and co-workers used PSC in order to synthesize poly(para-2,5-di-n-
hexylphenlene) (165) (Scheme 1.59).134 Starting from the suitable monomer 1,4-dibromo-di-
2,5-n-hexylbeutene137 (163) which is then converted to boronic acid derivative 164. The 
monomer was treated with Pd(PPh3)4 under reflux for 2 days to afford poly(para-2,5-di-n-
hexylphenlene) (165). A large number of poly(paraphenylene)s have been prepared based on 
this method.138-142
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Scheme 1.59 Synthesis of 165
Br Br
C6H13
C6H13
Br B(OH)2
C6H13
C6H13
1. n-Butyllithium, Hexane/Ether
B
O
O
O2. , Ether, -60
oC
3. aq. HCl
Br B(OH)2
C6H13
C6H13
Pd(PPh3)4
C6H6/2M. Na2CO3
Ref lux, 2d C6H13
C6H13
n
163 164
164 165
Page | 44
RESULTS AND 
DISCUSSION
CHAPTER TWO 
Results and Discussion 
Page | 45
2.1 Anthraquinones
Anthraquinones occur in many naturally occurring bioactive compounds. 143 For 
instance, the anthracyclines are important as antitumor agents and antibiotics (e.g., the natural 
products daunorubicin, adriamycin, and aclarubicin).144 Anthraquinone containing natural 
products include chrysophanic acid, vismiaquinone, anthragallol, and questin.145 Anthraquinone
derivatives show a very good antitumor activity against cancer cells.146 On the other hand, 
anthraquinones are widely using as antihelminthic187as well as inhibitor agents.148 Many 
applications of aryl-substituted anthraquinones exist in material sciences, due to their 
redox,149a,b UV and luminescence properties.149c,d They have also been used as stabilizers of 
light-modulating fluids.149e
2.1.1 Synthesis of 1,2-Diarylanthraquinones by Site-Selective Suzuki-Miyaura Cross-
Coupling Reactions of the Bis(triflate) of Alizarin
The phenol group can be transformed to triflates by treatment with triflic acid anhydride 
in the presence of pyridine.150 The triflic anhydride was added at -78 oC and the mixture was 
allowed to warm to r.t.
My strategy is based on the above mentioned procedure to convert the alizarin 186 into 
the bis(triflate) of alizarin 187 which was isolated as a yellow solid in 81% yield (Scheme 2.1).
Scheme 2.1 Synthesis of 187
O
O
OH
OH
O
O
OTf
OTfTf2O, CH2Cl2
Pyridine, -78 oC to r.t.
14 h
186 187
2.1.1.2 Synthesis of 1,2-Diarylanthraquinones 189a-f
1,2-Diarylanthraquinones 189a-f were synthesized by using Suzuki coupling reactions
of 1,2-bis(trifluoromethylsulfonyloxy)anthraquinone (187) and arylboronic acids (2.4 equiv) 
(Scheme 2.2). The best conditions for the completion of this coupling were the use of Pd(PPh3)4
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as the catalyst and K3PO4 as the base. I have done the Suzuki coupling reactions by using 
different substituted arylboronic acids including both electron-rich and electron-poor aryl 
groups. The coupling products were obtained in moderate to very good yields (40-81%). 
Scheme 2.2 Synthesis of 189a-f
O
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OTf
OTf
O
O
Ar
Ar
Dioxane,110 oC, 10h
ArB(OH)2
187 188a-f 189a-f
Pd(PPh3)4, K3PO4
The yield of 1,2-bis(4-methoxyphenyl)anthraquinone (189b) was low, due to hydrolysis 
of 187 to afford a monoarylhydroxyanthraquinone. The best yield was obtained for 1,2-bis(4-
chlorophenyl)anthraquinone (189d) which resulted in 81% yield. 1,2-Diarylanthraquinones 
189e,c,f were prepared in good yields. 1,2-Bis(4-trifluoromethylphenyl)anthraquinone (188a)
also gave a good yield (77%) (Table 1). 
                         Table 1 Synthesis of 189a-f   
188 189 Ar % (189)a
a a 4-(F3C)C6H4 77
b b 4-(MeO)C6H4 40
c c 4-t-BuC6H4 76
d d 4-ClC6H4 81
e e 4-MeC6H4 77
f f 4-EtC6H4 60
                                      a Yields of isolated products.
The structure of 1,2-bis(4-tert-butylphenyl)anthraquinone (189c) was confirmed by X-
ray crystal structure analysis as shown below in Figure 2.1. The anthraquinone unit is in plane. 
The tert-butyl-containing aromatic rings are twisted out of plane of the anthraquinone moiety.
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Figure 2.1 ORTEP plot of 189c
2.1.1.3 Site-Selective Synthesis of 1-Aryl-2-(trifluoromethylsulfonyloxy) anthraquinones
190a-h
The reaction of 187 with one equivalent of arylboronic acids gives rise to the issue of 
site-selectivity. The conditions of these reactions were optimized in order to get the best yield 
of 1-aryl-2-(trifluoromethylsulfonyloxy)anthraquinones. The best yields were obtained when 
Pd(PPh3)4 and K3PO4 were used and when the reaction was carried out at 90 oC during 10 h 
(Scheme 2.3).
Scheme 2.3 Site-selective synthesis of 190a-h
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187 188a-d,g-j 190a-h
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Arylboronic acids 188d and 188g gave the best yields (85 and 84%). Arylboronic acids 
188a,h and 188b,c were afforded in good yields. Moderate yields were obtained for reactions of 
188i,j (50 and 52%) (Table 2). 
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                          Table 2 Synthesis of 190a-h
188 190 Ar % (190)a
a a 4-(F3C)C6H4 74
b b 4-(MeO)C6H4 67
c c 4-t-BuC6H4 61
d d 4-ClC6H4 85
g e 3-(F3C)C6H4 84
h f 3-(MeO)C6H4 79
i g 4-FC6H4 50
j h 4-(CF3O)C6H4 52
                                     a Yields of isolated products.
The first nucleophilic attack occurred at carbon atom C-1. This can be explained by the 
-acceptor effect of the carbonyl group (Figure 2.2). The site-selective formation of 190a-h can 
be explained by electronic reasons. The first attack of palladium(0)-catalyzed cross-coupling 
reactions generally occurs at the electronically more deficient and sterically less hindered 
position.151,152 Position 1 of 187 is sterically more hindered than position 2 (Figure 2.3). 
However, position 1 (located in -position to the carbonyl group) is more electron-deficient 
than position 2. In fact, the 1H-NMR signals of aromatic protons located at position 1 are 
generally shifted to lower field compared to the protons located at position 2.152 In addition, a 
neighboring group effect by the quinone carbonyl group (chelation of the approaching 
palladium complex) might play a role. In conclusion, the first attack occurs at the sterically 
more hindered position, due to electronic reasons. 
Figure 2.2 -Acceptor effect of the carbonyl group
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O
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Figure 2.3 Possible explanation for the site-selectivity of 187
O
O
OTf
OTf
sterically more hindered
electronically more deficient
sterically less hindered
electronically less deficient
A 1H, 1H NOE experiment was used to confirm the structure of compound 190c. The 
1H, 1H NOE spectrum does not provide us a real proof for the site-selectivity. The missing 
correlations give us an indirect hint to the structure of 190c (Figure 2.4).
Figure 2.4 1H, 1H NOE spectrum of 190c
In addition to the 1H, 1H NOE experiment, a better proof to the site-selective attack at 
carbon atom C-1 190b was obtained by using X-ray crystal structure analysis (Figure 2.5). The 
aromatic ring is perpendicular to the anthraquinone system.
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Figure 2.5 ORTEP plot of 190b
2.1.1.4 Synthesis of Unsymmetrical 1,2-Diarylanthraquinones 191a-f
The possibilities of one-pot Suzuki coupling reactions of 187 with two different 
arylboronic acids were next studied. The boronic acids were added in a sequential manner. 
During the optimization, it proved to be important to carry out the first step of the one-pot 
reaction at 90 °C and the second step at 110 °C (Scheme 2.4).
Scheme 2.4 Site-selective synthesis of unsymmetrical anthraquinones 191a-f
Dioxane, Pd(PPh3)4, K3PO4
Ar1 =
C(CH3)3
Ar2 =
Cl
1. Ar1B(OH)2 90 oC, 10 h
188a,b,c,d,g,g
O
O
OTf
OTf
O
O
Ar1
Ar2
187 191a-f
2. Ar2B(OH)2 110 oC, 10 h
188c,c,a,c,a,c
Products 191a,c,d,e,f were isolated in moderate yields between 61-68%, except for 
191b which resulted in a moderate yield (50%) (Table 3). 
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       Table 3 Synthesis of 191a-f
188 191 Ar1 Ar2 % (191)a
a,c a 4-(F3C)C6H4 4-t-BuC6H4 65
b,c b 4-(MeO)C6H4 4-t-BuC6H4 50
c,a c 4-t-BuC6H4 4-(CF3)C6H4 60
d,c d 4-ClC6H4 4-t-BuC6H4 61
g,a e 3-(F3C)C6H4 4-(CF3)C6H4 68
g,c f 3-(F3C)C6H4 4-t-BuC6H4 61
            a Yields of isolated products.
For compound 191a an X-ray crystal structure was measured and the structure was 
confirmed (Figure 2.6). The aromatic rings are perpendicular to the anthraquinone moiety. Both 
the CF3 and the t-Bu group are disordered.
Figure 2.6 ORTEP plot of 191a
Results and Discussion 
Page | 52
2.1.2 Synthesis of 1,2,3-Triarylanthraquinones by Site-Selective Suzuki–Miyaura Cross-
coupling Reactions of the Tris(triflate) of Purpurin
The reaction of commercially available purpurin with triflic acid anhydride, in the 
presence of pyridine, afforded the tris(triflate) of purpurin in 43% yield.  The reaction was done 
at -78 oC and allowed to warm to r.t. under an inert atmosphere with stirring for 14 h (Scheme 
2.5). 
Scheme 2.5 Synthesis of 193
O
O
OH
OH
O
O
OTf
OTfTf2O, CH2Cl2
Pyridine, -78 oC to r.t.
14 hOH OTf
192 193
2.1.2.1 Synthesis of 1,2,3-Triarylanthraquinones 194a-f
The reaction of the tris(tiflate) of purpurin 193 with 4.0 equivelants of boronic acid 
derivatives  afforded 1,2,3-triarylanthraquinones. In the reactions were used Pd(PPh3)4 as the 
catalyst and K3PO4 as the base. The best temperature was 120 oC (Scheme 2.6). 
Scheme 2.6 Synthesis of 194a-f
O
O
OTf
OTf
O
O
Ar
Ar
Dioxane,120 oC, 12 h
ArB(OH)2
193 188a-d,i,k 194a-f
Pd(PPh3)4, K3PO4
ArOTf
Arylboronic acids 188c,k gave very good yields (83 and 86%). Arylboronic acids
188b,d and 188a,i provided moderate to good yields (Table 4).
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                         Table 4 Synthesis of 194a-f
188 194 Ar % (194)a
a a 4-(F3C)C6H4 43
b b 4-(MeO)C6H4 73
c c 4-t-BuC6H4 83
d d 4-ClC6H4 60
i e 4-FC6H4 57
k f C6H4 86
                                   a Yields of isolated products.
2.1.2.2 Site-Selective Synthesis of 1,4-Diaryl-2-(
trifluoromethylsulfonyloxy)anthraquinones 195a-e
The reaction of the tris(triflate) of purpurin 193 and 2.0 equivalents of arylboronic acids 
afforded 1,4-diaryl-2-(trifluoromethylsulfonyloxy)anthraquinones 195a-e. During the 
optimization, it was proved to be important to carry out the reaction at 105 °C and the reaction 
had to be stirred for 10 h (Scheme 2.7).
Scheme 2.7 Site-selective synthesis of 195a-e
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OTf
Dioxane,105 oC, 10 h
ArB(OH)2
193 188a,c,e,f,l 195a-e
Pd(PPh3)4, K3PO4
ArOTf
Arylboronic acids 188c,f afforded the corresponding products in very good yield (83
and 86%). For 188l a moderate yield was obtained (60%). Moderate yields were observed for 
188a,e (57 and 43%) (Table 5). 
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                        Table 5 Synthesis of 195a-e
188 195 Ar % (195)a
a a 4-(F3C)C6H4 61
c b 4-t-BuC6H4 81
e c 4-MeC6H4 51
f d 4-EtC6H4 74
l e 3,5-MeC6H4 60
                                     a Yields of isolated products.
In order to determine the structure of compound 195e, a 1H, 1H NOE experiment was 
used. The correlation (black circle) shows that the attack of the boronic acid occurred at carbon 
atom C-4. The missing correlation (red circle) shows that carbon atom C-2 was not attacked 
(Figure 2.7).
Figure 2.7 1H, 1H NOE spectrum of 195e
Inspection of the 1H-NMR shows that the aromatic protons are almost equivalent, which 
suggests a relatively symmetrical structure containing aryl groups located at carbon atom C-1 
and C-4 (Figure 2.8)
Results and Discussion 
Page | 55
Figure 2.8 1H-NMR spectrum of 195e
The structure of 195a was confirmed by X-ray crystal structure analysis. Both CF3
containing aromatic rings are perpendicular to the anthraquinone moiety (Figure 2.9).
Figure 2.9 ORTEP plot of 195a
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2.1.2.3 Site-Selective Synthesis of 1,2-Bis(trifluoromethylsulfonyloxy)-4-
arylanthraquinones 196a-f
Site-Selective Suzuki-Miyaura coupling reactions were achieved between tris(triflate) of 
purpurin 193 with 1.0 equivalent of arylboronic acids. The temperature was optimized to be 95 
oC and the reaction was allowed to stirr for 10 h (Scheme 2.8). 
Scheme 2.8 Site-selective synthesis of 196a-f
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Dioxane, 95 oC, 10 h
ArB(OH)2
193 188b,c,e,f,g,m 196a-f
Pd(PPh3)4, K3PO4
ArOTf
Arylboronic acids 188c,d resulted in moderate yields (61 and 65%). Arylboronic acid
188f gave 56% yield of product. Arylboronic acids 188b,c,g gave moderate yields (40, 38 and 
40%) (Table 6). 
                       Table 6 Synthesis of 196a-f
188 196 Ar % (196)a
b a 4-(MeO)C6H4 38
c b 4-t-BuC6H4 41
e c 4-MeC6H4 61
f d 4-EtC6H4 65
g e 3-(F3C)C6H4 40
m f 3-ClC6H4 56
                                      a Yields of isolated products.
The first attack of palladium(0)-catalyzed cross-coupling reactions generally occurs at 
the electronically more deficient and sterically less hindered position.187,188  Position 2 and 4 of
193 are sterically less hindered than position 1 (Figure 2.10). Positions 1 and 4 of 193 are more
electron-deficient than position 2. In conclusion, the first attack occurs at the sterically less 
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hindered and electronically deficient position 4. The second attack occurs at position 1 which is 
sterically hindered, but electron deficient. The third attack occurs at position 2 which is not 
electron deficient and not sterically hindered.
Figure 2.10 Possible explanation for the site-selectivity of 193
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electronically deficient
The structure of 196f was determined by 2D NMR experiments. The 1H, 1H NOE 
correlation shows that the attack of the arylboronic acid occurred at carbon atom C-4 (Figure 
2.11). 
Figure 2.11 1H, 1H NOE spectrum of 196f
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The 1H-NMR spectrum of 196f shows that two aromatic protons beside the carbonyl 
groups are not equivalent to each other, which suggests a relatively unsymmetrical structure 
containing the aryl groups located at position 4 (Figure 2.12).
Figure 2.12 1H-NMR spectrum of 196f
The structure of 196e was independently confirmed by X-ray crystal structure analysis. 
The aryl groups are twisted out of plane. The SO3CF3 group and the CF3 group are disordered
(Figure 2.13).
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Figure 2.13 ORTEP plot of 196e
2.1.2.4 Synthesis of Unsymmetrical 1,4-Bis(4-tert-butylphenyl)-2-(4-
chlorophenyl)anthraquinone (197)
The one-pot reaction of tris(tiflate) of purpurin 193 and different arylboronic acids 
afforded the 1,4-bis(4-tert-butylphenyl)-2-(4-chlorophenyl)anthraquinone (197). The first step 
of the reaction was carried out using 2.0 equivalents of arylboronic acid at 95 oC during 10 h. 
The second step was carried out at 110 oC during 10 h (Scheme 2.9). 1,4-Bis(4-tert-
butylphenyl)-2-(4-chlorophenyl)anthraquinone (197) was obtained in 45% yield.
Scheme 2.9 Synthesis of unsymmetrical 197
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Dioxane, Pd(PPh3)4, K3PO4
193 197
OTf Ar1
Ar1 =
C(CH3)3
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Cl
1. Ar1B(OH)2 95 oC, 10 h
188c
2. Ar2B(OH)2 110 oC, 10 h
188d
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2.2 Hydroxyphthalates
Functionalized hydroxylated benzoates and benzodioates and their derivatives are of 
great interest as lead structures in pharmaceutical, industrial and agricultural chemistry and 
constitute valuable synthetic building blocks in synthetic organic chemistry.153 Some of these 
molecules occur in natural products and have interesting pharmacological properities, including 
analgesic, antipyretic, antimicrobial and fungicidal prosperities. In addition, they act as 
inhibitors of some enzymes and as inhibitors for the absorption of steroids, such as, cholesterol 
and bile acids.154
2.2.1 Synthesis of Dimethyl 3,5-Dihydoxyphthalates by [4+2]-Cycloaddition and 
Subsequent Site-Selective Suzuki-Miyaura Cross-Coupling Reactions
I synthesized dimethyl 3,5-dihydroxyphthalate (200) by [4+2]-cycloaddition of 1-
methoxy-1,3-bis(trimethylsilyloxy)-1,3-diene with dimethyl acetylenedicarboxylate (DMAD)
in 32% yield. DMAD was added at r.t. and the mixture was allowed to stirr at 50 oC for 48 h. 
Toluene was used as the solvent (Scheme 2.10). 
Scheme 2.10 Synthesis of 200
MeO
Me3SiO
OSiMe3 MeO2C CO2Me
Toluene, r.t. to 50 oC
198 199 200
OH
HO
OMe
OMe
O
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The reaction of dimethyl 3,5-dihydoxyphthalate (200) with triflic acid anhydride 
resulted in formation of dimethyl 3,5-bis(trifluoromethylsulfonyloxy)phthalate (201) in good 
yield (78%) (Scheme 2.11).
Scheme 2.11 Synthesis of 201
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Pyridine, -78 oC to r.t.
14 h
Tf2O, CH2Cl2
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The reaction of dimethyl 3,5-bis(trifluoromethylsulfonyloxy)phthalates (201) with 2.4 
equivalents of arylboronic acids afforded dimethyl 3,5-diarylphthalates 202a,b (Table 7). The 
temperature, which was selected, was 110 oC (8 h). Dioxane was used in this reaction as 
suitable solvent and the base K3PO4 was used (Scheme 2.12). 
Scheme 2.12 Synthesis of 202a,b
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201 188c,d 202a,b
               
                        Table 7 Synthesis of 202a,b
188 202 Ar % (202)a
c a 4-t-BuC6H4 91
d b 4-ClC6H4 88
                                   a Yields of isolated products.
The conditions were optimized for the reaction of dimethyl 3,5-
bis(trifluoromethylsulfonyloxy)phthalate (201) with 1 equivalent  of arylboronic acids (Scheme 
2.13). The reaction was carried out at 70 oC during 16 h. As the catalyst, 6 mol% of Pd(PPh3)3 
was used. Products 203a,b were isolated  in good yields (76 and 71%) (Table 8). 
Scheme 2.13 Site-selective synthesis of 203a,b
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            Table 8 Synthesis of 203a,b
188 203 Ar % (203)a
a a 4-(F3C)C6H4 76
c b 4-t-BuC6H4 71
                                     a Yields of isolated products.
Based on a 1H, 1H NOE experiment for product 203b, it was confirmed that the first 
attack of the arylboronic acid occurred at carbon atom C-5 (Figure 2.14). The two protons at 
carbon atom C-4 and C-6, which appear as doublets at 7.62 and 8.11 ppm with coupling 
constants J = 1.62 Hz, correlate with the aromatic protons which appear as singlets.
Figure 2.14 1H, 1H NOE spectrum of 203b
2.3 Quinolines 
Quinolines are the core for many naturally occurring compounds.155 They are also very 
important as pharmacologically active substances. For example, pyrimidinylthiopyrimidinyloxy 
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quinoline derivatives are active as herbicides, microbicides, and fungicides.156 Camptothecin is 
a natural product isolated in 1966 and shows excellent antitumor activity.157
2.3.1 Synthesis of 5,7-Diaryl-8-(trifluoromethylsulfonyloxy)quinolines by Site-Selective 
Suzuki-Miyaura Cross-Coupling Reactions
5,7-Dibromo-8-(trifluoromethylsulfonyloxy)quinoline (205) was synthesized by 
reaction of 5,7-dibromo-8-hydroxyquinoline with triflic acid anhydride and afforded product 
205 in very good yield (80%) (Scheme 2.14).  
Scheme 2.14 Synthesis of 205
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The reaction of 205 with 2.0 equivalent of 4-tert-butylphenylboronic acid afforded 
product 206 in 81% yield (Scheme 2.15). The optimization of the product 206 required to do 
this reaction at 70 oC and using K2CO3 as the base. The first attack occurred at carbon atom C-5 
and the second attack occurred at carbon atom C-7.   
Scheme 2.15 Site-selective synthesis of 206  
N
Br
Br
OTf
Dioxane, 70 oC, 12 h
Pd(PPh3)4, K2CO3
205 188c 206 (81%)
B(OH)2
C(CH3)3
N
OTf
C(CH3)3
(H3C)3C
The reaction of 5,7-dibromo-8-(trifluoromethylsulfonyloxy)quinoline (205) with 1 
equivalent of 4-tert-butylphenylboronic acid gave 5-(4-tert-butylphenyl)-7-bromo-8-
Results and Discussion 
Page | 64
(trifluoromethylsulfonyloxy)quinoline (207) in good yield (75%). I carried out this reaction at 
50 oC for 20 h. I again used K2CO3 as the base (Scheme 2.16). The attack occurred selectively 
at carbon atom C-5. 
Scheme 2.16 Site-selective synthesis of 207
N
Br
Br
OTf
Dioxane, 50 oC, 20 h
Pd(PPh3)4, K2CO3
205 188c 207 (75%)
B(OH)2
C(CH3)3
NBr
OTf
C(CH3)3
         
The structure of compound 207 was confirmed by using 1H, 1H NOE experiments. The 
ortho protons of the 4-tert-butylphenyl group correlate with proton H-4 of the quinoline moiety 
(Figure 2.15). 
Figure 2.15 1H, 1H NOE spectrum of 207
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In English 
Based on the methodology of Suzuki-Miyaura cross-coupling reactions, a wide range of 
substituted anthraquinones are now readily available including a few examples of phthalates 
and quinolines. The method provides new possibilities in carbon-carbon bond formation for the 
preparation of new materials. Due to the importance and useful properties of many 
anthraquinones, phthalates and quinolines, the chemistry of the bis(triflates) of anthraquinones, 
phthalates and 5,7-dibromo-8-(trifluoromethylsulfonyloxy)quinoline has been investigated in 
this thesis. The results for the synthesis and characterization of diarylanthraquinones, 
diarylphthalates and diarylquinolines are presented in this thesis.
In German
Basierend auf der Methode der Suzuki-Miyaura-Kreuzkupplungsreaktion ist nun eine 
große Auswahl substituierter Anthrachinone, einschließlich einiger Beispiele für  substituierte 
Phthalate und Chinoline, leicht verfügbar. Die Methode bietet neue Möglichkeiten in der C-C-
Bindungsknüpfung, um neue Materialien zu synthetisieren. Wegen der großen Bedeutung und 
den nützlichen Eigenschaften vieler Anthrachinone, Phthalate und Chinoline wurde die Chemie 
der Bis(triflate) von Anthrachinonen, Phthalaten und 5,7-Dibrom-8-
(trifluormethylsulfonyloxy)chinolinen in der vorliegenden Arbeit untersucht. Die Ergebnisse 
der Synthese und der Charakterisierung von Diarylanthrachinonen, Diarylphthalaten und 
Diarylchinonen werden in dieser Arbeit gezeigt und diskutiert.
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3.1 Materials and Methods
3.1.1 General: Equipment, Chemicals and Work Technique
1H-NMR Spectroscopy
Bruker: AM 250, ! #
$ &<<? ! #
$ @<<Z \ 	 <^<<  
_Z\	{^<|#}-~Z\	^{~3); 2.50 ppm for d-6 
DMSO-; Characterization of the signal fragmentations: s = singlet, d = doublet, dd =double of 
doublet, ddd = doublet of a double doublet, t = triplet, q = quartet, quint = quintet; sext = 
Sextet, sept = Septet, m = multiplet, br = broadly. Spectra were evaluated according to first 
order rule. All coupling constants are indicated as (J).
13C-NMR Spectroscopy
Bruker: AM 250, (62.9 MHz); Bruker: ARX 300, (75.4 MHz), Bruker: ARX 500, (125 
MHz) Ref: 29.84 ± 0.01 ppm and 206.26 ± 0.13 ppm for (CD3)2^ \ 	 {^<<  
Acetone d-~Z\	^<<3. The multiplicity of the carbon atoms was determined 
by the DEPT 135 and APT technique (APT = Attached Proton Test) and quoted as CH3, CH2, 
CH and C for primary, secondary, tertiary and quaternary carbon atoms. Characterization of the 
signal fragmentations: quart = quartet the multiplicity of the signals was determined by the 
DEPT recording technology and/or the APT recording technology.
Mass Spectroscopy (MS)
AMD MS40, AMD 402 (AMD Intectra), Varian MAT CH 7, MAT 731.
High Resolution Mass Spectroscopy (HRMS)
Finnigan MAT 95 or Varian MAT 311; Bruker FT CIR, AMD 402 (AMD Intectra).
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Infrared Spectroscopy (IR)
Bruker IFS 66 (FT IR), Nicolet 205 FT IR; Nicolet Protégé 460, Nicolet 360 Smart 
Orbit (ATR); KBr , KAP, Nujol, and ATR; Abbreviations for signal allocations: w = weak, m 
= medium, s = strong, br = broad.
Elementary Analysis 
LECO CHNS-932, Thermoquest Flash EA 1112.
X-ray Crystal Structure Analysis
Bruker X8Apex Diffractometer with CCD-Kamera (Mo-Ka und Graphit 
?	<^<&Å).
Melting Points
Micro heating table HMK 67/1825 Kuestner (Büchi apparatus); Melting points are 
uncorrected.
Column Chromatography
Chromatography was performed over Merck silica gel 60 (0,063 - 0,200 mm, 70 - 230 
mesh) as normal and/or over mesh silica gel 60 (0,040 - 0,063 mm, 200 - 400 mesh) as Flash 
Chromatography. All solvent were distilled before use.
TLC
Merck DC finished foils silica gel 60 F254 on aluminum foil and Macherey finished 
foils Alugram® Sil G/UV254. Detection under UV light with 254 nm and/or 366 nm without 
dipping reagent, as well as with anisaldehyde sulfuric acid reagent (1 mL anisaldehyde 
consisting in 100 mL stock solution of 85% methanol, 14% acetic acid and 1% sulfuric acid).
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Chemicals and Work Technique 
All solvents for using were distilled by standard methods. All reactions were carried out 
under an inert atmosphere, oxygen and humidity exclusion. All of the chemicals are standard, 
commercially available from Merck®, Aldrich®, Arcos® and others. The order of the 
characterized connections effected numerically, but does not correspond to the order in the 
main part of dissertation.
3.2 Preparative Procedures and Spectroscopic Data 
3.3 Synthesis of 1,2-Bis(trifluoromethylsulfonyloxy)anthraquinone (187)
To a solution of 1,2-dihydroxyanthraquninone (186) (1.0 equiv) in CH2Cl2 (10 
mL/mmol) was added pyridine (4.0 equiv) at room temperature under an argon atmosphere. 
After 10 min, Tf2O (2.4 equiv) was added at -78 °C. The mixture was allowed to warm up to 
room temperature and stirred for overnight. The reaction mixture was filtered and the filtrate 
was concentrated in vacuo. The products of the reaction mixture were isolated by rapid column 
chromatography (flash silica gel, heptanes/EtOAc). 
1,2-Bis(trifluoromethylsulfonyloxy)anthraquinone (187)
To a solution of 186 (1.0 equiv.) in CH2Cl2 (10 mL/mmol) was added 
pyridine (4.0 equiv.) at room temperature under an argon atmosphere. 
After 10 min, Tf2O (2.4 equiv.) was added at -78 °C. The mixture was 
allowed to warm up to room temperature and stirred for overnight. The 
reaction mixture was filtered and the filtrate was concentrated in vacuo. The products of the 
reaction mixture were isolated by rapid column chromatography (flash silica gel, 
heptanes/EtOAc). Starting with 186 (1.9 g, 8.0 mmol), pyridine (2.6 mL, 32.0 mmol), CH2Cl2
(80 mL), Tf2O (3.2 mL, 19.2 mmol), 187 was isolated as a yellow solid (3.25 g, 81%), mp 152-
154 oC. 1H NMR (300 MHz, CDCl3):  = 7.80-7.85 (m, 3H, ArH), 8.23-8.26 (m, 1H, ArH), 
8.29-8.32 (m, 1H, ArH), 8.46 (d, J = 8.76 Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 
118.5 (q, JF,C = 320.9 Hz, CF3), 118.6 (d, JF,C = 320.7 Hz, CF3), 127.4 (CH), 127.8 (C), 128.0, 
128.1, 128.9 (CH), 132.0, 133.7, 134.1 (C), 135.1, 135.2 (CH), 139.2, 145.0 (C), 180.2, 180.5 
(CO). 19F NMR (282 MHz, CDCl3):   = -73.4 (q, JF = 3.02, 6.02 Hz, 3F, CF3), -72.58 (q, JF =
O
O
OTf
OTf
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2.84, 5.83 Hz, 3F, CF3). IR (KBr, cm1):   = 1674 (s), 1601, 1587, 1472 (w), 1427 (s), 1330, 
1316, 1282, 1249 (w), 1208 (s), 1164, 1150 (m) 1124 (s), 1007, 998, 901, 856 (m), 807 (s), 
795, 738 (m), 721, 708 (s), 684, 676, 655, 643 (w), 618, 606 (m), 589, 575, 569 (s), 543, 529 
(m). GC-MS (EI, 70 eV): m/z (%) = 504 ([M+H]+, 36), 435 (05), 375 (08), 348 (23), 279 (100), 
251 (76), 223 (26), 154 (26), 126 (60). HRMS (EI, 70 eV): calcd for C16H6O8F6S2 [M]+: 
503.94028, found 503.940108.
3.3.1 General Procedure for Suzuki-Miyaura Reactions
A 1,4-dioxane solution (4 mL per 3 mmol of 187) of 187, K3PO4, Pd(PPh3)4 and 
arylboronic acid 188 was stirred at 110 °C or 90 °C for 10 h. After cooling to 20 °C, distilled 
water was added. The organic and the aqueous layers were separated and the latter was 
extracted with CH2Cl2. The combined organic layers were dried (Na2SO4), filtered and the 
filtrate was concentrated in vacuo. The residue was purified by column chromatography.
1,2-Bis(4-trifluoromethylphenyl)anthraquinone (189a)
Starting with 187 (250 mg, 0.5 mmol), 188a (225 mg, 1.2 
mmol), Pd(PPh3)4 (34 mg, 6 mol-%, 0.03 mmol), K3PO4 (320 
mg, 1.5 mmol) and 1,4-dioxane (4 mL), 189a was isolated as a 
yellow solid (190 mg, 77%), mp 208-210 oC. 1H NMR (300 
MHz, CDCl3):  = 7.01-7.07 (m, 4H, ArH), 7.35 (d, J = 8.12 
Hz, 2H, ArH), 7.42 (d, J = 8.12 Hz, 2H, ArH), 7.62-7.71 (m, 
3H, ArH), 7.95-8.0 (m, 1H, ArH), 8.18-8.21 (m, 1H, ArH), 8.45 (d, J = 8.12 Hz, 1H, ArH). 13C
NMR (62.9 MHz, CDCl3):  = 123.8 (q, JF,C = 272.2 Hz, CF3), 124.1 (q, JF,C = 272.1 Hz, CF3), 
124.7 (C), 124.7, 124.8, 126.7, 127.4, 127.7 (CH), 128.8 (C), 129.5, 129.7 (CH), 131.5, 132.6 
(C), 134.0 (CH), 134.3 (C), 134.4 (CH), 134.5 (C), 135.1 (CH), 140.6, 143.0, 143.2, 147.3 (C), 
182.7, 183.3 (CO). 19F NMR (282 MHz, CDCl3):  = -62.69 (s, 3F, CF3), -62.37 (s, 3F, CF3). 
IR (KBr, cm1):  = 1670 (m), 1633, 1615, 1580, 1416, 1397 (w), 1324, 1299 (s), 1281, 1261, 
1212, 1199 (m), 1158, 1108, 1078, 1061, 1016 (s), 977 (w), 958, 947 (m), 900, 866 (w), 835, 
825 (s), 797 (m), 787, 768, 757, 747, 740 (w), 720, 711 (s), 679 (w), 672 (m), 648 (w), 636 
(m), 606 (s), 545 (w). GC-MS (EI, 70 eV): m/z (%) = 496 ([M]+, 78), 495 (100), 477 (09), 428 
(25), 427 (86). HRMS (EI, 70 eV): calcd for C28H13O2F6 [M-H]+: 495.08143, found 
495.081086.
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1,2-Bis(4-methoxyphenyl)anthraquinone (189b)
Starting with 187 (250 mg, 0.5 mmol), 188b (180 mg, 1.2 
mmol), Pd(PPh3)4 (34 mg, 6 mol-%, 0.03 mmol), K3PO4 (320 
mg, 1.5 mmol) and 1,4-dioxane (4 mL), 189b was isolated as a 
red crystal (84 mg, 40%), mp 220-221 oC. 1H NMR (300 MHz, 
CDCl3):  = 3.66 (s, 3H, OCH3), 3.71 (s, 3H, OCH3), 6.61 (d, J
= 8.76 Hz, 2H, ArH), 6.71 (d, J = 8.73 Hz, 2H, ArH), 6.83 (d, J
= 7.92 Hz, 4H, ArH), 7.60-7.65 (m, 3H, ArH), 7.97-8.0 (m, 1H, ArH), 8.15-8.18 (m, 1H, ArH), 
8.30 (d, J = 8.07 Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 54.0 (OCH3), 54.1 (OCH3),
112.1, 112.2, 125.4, 126.0, 126.3, 129.4, 129.6 (CH), 130.8, 131.0, 131.4, 131.7 (C), 132.4 
(CH), 132.5 (C), 133.0 (CH), 134.0 (C), 134.2 (CH), 140.0, 148.0, 157.1, 157.5 (C), 182.3, 
183.0 (CO). IR (KBr, cm1):  = 2838 (w), 1671 (s), 1606 (m), 1588, 1550, 1516, 1464, 1451, 
1440, 1412, 1394 (w), 1328, 1311 (m), 1297, 1240 (s), 1208, 1107, 1088, 1074 (m), 1027 (s), 
977 (w), 954 (s), 858 (w), 840 (m), 828 (s), 811 (w), 800 (s), 767, 749 (w), 727 (m), 718 (s), 
697 (m), 669, 649 (w), 640, 601, 588 (m), 537 (s). GC-MS (EI, 70 eV): m/z (%) = 420 ([M]+, 
100), 419 (49), 405 (11), 390 (12), 389 (45), 345 (14), 312 (09). HRMS (EI, 70 eV): calcd for 
C28H20O4 [M]+: 420.13561, found 420.134505.
1,2-Bis(4-tert-butylphenyl)anthraquinone (189c)
Starting with 187 (250 mg, 0.5 mmol), 188c (213 mg, 1.2 
mmol), Pd(PPh3)4 (34 mg, 6 mol-%, 0.03 mmol), K3PO4
(320 mg, 1.5 mmol) and 1,4-dioxane (4 mL), 189c was 
isolated as an orange crystal (180 mg, 76%), mp 234-236 
oC. 1H NMR (300 MHz, CDCl3):  = 1.15 (s, 9H, 3CH3), 
1.20 (s, 9H, 3CH3), 6.75-6.83 (m, 4H, ArH), 7.01-7.14 (m, 
4H, ArH), 7.60-7.65 (m, 2H, ArH), 7.71 (d, J = 8.01 Hz, 1H, ArH). 8.01-8.03 (m, 1H, ArH), 
8.17-8.23 (m, 1H, ArH), 8.34 (d, J = 8.05 Hz, 1H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 
31.2 (3CH3), 31.4 (3CH3), 34.4, 34.4 (C), 124.2, 124.3, 126.6, 127.0, 127.5, 129.0, 129.0 (CH), 
131.3, 132.9 (C), 133.5 (CH), 133.6 (C), 134.1, 134.9 (CH), 135.0, 136.9, 137.2, 142.7, 149.1, 
149.8, 149.8 (C), 183.4, 183.7 (CO). IR (KBr, cm1):  = 2959 (m), 2901, 2866 (w), 1675 (s), 
1663,  1588 (m), 1575, 1566, 1548, 1513, 1475, 1456, 1410, 1394, 1360 (w), 1330, 1315 (m), 
1298 (s),  1280, 1262, 1253, 1211, 1199 (m), 1185, 1160 (w), 1113 (m), 1072 (w), 1016 (m), 
O
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979 (w), 956 (m), 942, 904 (w), 860, 836 (m), 822(s), 795 (m), 774, 768, 755, 745  (w), 719 
(s), 690 (m), 682 (w), 662, 645 (m), 587 (s), 568, 559, 543 (m). GC-MS (EI, 70 eV): m/z (%) = 
472 ([M]+, 45), 457 (93), 439 (04), 415 (100), 401 (23), 383 (11). HRMS (EI, 70 eV): calcd for 
C34H32O2 [M]+: 472.23968, found 472.238675.
1,2-Bis(4-chlorophenyl)anthraquinone (189d)
Starting with 187 (250 mg, 0.5 mmol), 188d (185 mg, 1.2 mmol), 
Pd(PPh3)4 (34 mg, 6 mol-%, 0.03 mmol), K3PO4 (320 mg, 1.5 
mmol) and 1,4-dioxane (4 mL), 189d was isolated as a yellow 
solid (174 mg, 81%), mp 208-210 oC. 1H NMR (300 MHz, 
CDCl3):  = 6.82-6.87 (m, 4H, ArH), 7.06-7.16 (m, 4H, ArH), 
7.61-7.70 (m, 3H, ArH), 7.95-8.02 (m, 1H, ArH), 8.15-8.18 (m, 
1H, ArH), 8.34 (d, J = 8.01 Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 126.7, 127.4, 
127.5, 128.1, 128.2, 130.5, 130.7 (CH), 131.6, 132.6, 132.8, 133.6 (C), 133.8 (CH), 134.0 (C), 
134.3 (CH), 134.6 (C), 135.1 (CH), 137.9, 138.1, 140.8, 147.7 (C), 183.0, 183.5 (CO). IR 
(KBr, cm1):  = 1673 (s), 1589 (m), 1576, 1551 (w), 1489 (m), 1478, 1451, 1410, 1388 (w), 
1326 (m), 1308, 1297, 1267 (s), 1245, 1210 (m), 1181 (w), 1159 (m), 1091 (s), 1070 (m), 1014 
(s), 972 (w), 954 (s), 938, 856, 846 (m), 834, 820 (s), 791, 774, 763, 729 (m), 714 (s), 698, 688 
(m), 656 (w), 644 (m), 636, 573 (w), 559, 548 (m), 537 (w). GC-MS (EI, 70 eV): m/z (%) = 
432 ([M]+, 2x 37Cl, 12), 431 ([M+H]+, 37Cl, 26), 430 ([M]+, 37Cl, 67), 429 ([M+H]+, 35Cl, 91), 
428 ([M]+, 35Cl, 93), 427 (100), 395 (30), 394 (24), 393 (91), 357 (17), 300 (26). HRMS (EI, 
70 eV): calcd for C26H13Cl2O2 ([M-H]+, 35Cl): 427.02871, found 427.028111.
1,2-Bis(4-methylphenyl)anthraquinone (189e)
Starting with 187 (250 mg, 0.5 mmol), 188e (162 mg, 1.2 
mmol), Pd(PPh3)4 (34 mg, 6 mol-%, 0.03 mmol), K3PO4 (320 
mg, 1.5 mmol) and 1,4-dioxane (4 mL), 189e was isolated as a 
yellow solid (149 mg, 77%), mp 218-220 oC. 1H NMR (300 
MHz, CDCl3):  = 2.20 (s, 3H, CH3), 2.27 (s, 3H, CH3), 6.82-
7.00 (m, 4H, ArH), 6.90 (d, J = 7.86 Hz, 2H, ArH), 6.98 (d, J = 
7.88 Hz, 2H, ArH), 7.60-7.70 (m, 3H, ArH), 8.00-8.03 (m, 1H, ArH), 8.18-8.21 (m, 1H, ArH), 
8.34 (d, J = 8.01Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 21.1 (CH3), 21.4 (CH3), 
126.5, 127.0, 127.4, 128.4, 128.5, 129.1, 129.3 (CH), 131.8, 132.8, (C). 133.5 (CH), 133.6 (C), 
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134.1 (CH), 135.1 (C), 135.3 (CH), 136.0, 136.7, 136.8, 137.2, 142.4, 149.2 (C), 183.4, 183.9 
(CO). IR (KBr, cm1):  = 2920, 2851 (w), 1672, 1662 (s), 1590, 1574, 1548, 1512, 1478, 
1445, 1414, 1385 (w), 1327, 1313 (m), 1293, 1278, 1260 (s), 1241, 1208 (m), 1182, 1159, 
1112, 1070, 1039 (w), 1018 (m), 965 (w), 952, 939 (m), 896, 854, 832 (w), 811 (s), 794 (m), 
762, 749 (w), 723, 713, 701 (s), 669, 650 (w), 642 (m), 595 (w), 580, 549, 540 (m). GC-MS 
(EI, 70 eV): m/z (%) = 388 ([M]+, 49), 374 (26). 373 (100), 371 (6). HRMS (EI, (m), 70 eV): 
calcd for C28H20O2 [M]+: 388.14578, found 388.144687.
1,2-Bis(4-ethylphenyl)anthraquinone (189f)
Starting with 187 (250 mg, 0.5 mmol), 189f (180 mg, 1.2 
mmol), Pd(PPh3)4 (34 mg, 6 mol-%, 0.03 mmol), K3PO4
(320 mg, 1.5 mmol) and 1,4-dioxane (4 mL), 189f was 
isolated as a brown solid (124 mg, 60%), mp 146-148 oC. 
1H NMR (300 MHz, CDCl3):  = 1.03-1.14 (m, 6H, 2CH3), 
2.43-2.55 (m, 4H, 2CH2), 6.76-6.87 (m, 6H, ArH), 6.95 (d, J
= 8.07 Hz, 2H, ArH), 7.54-7.64 (m, 3H, ArH), 7.94-8.01 (m, 1H, ArH), 8.11-8.14 (m, 1H, 
ArH), 8.27 (d, J = 8.04 Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 14.2 (CH3), 14.4 
(CH3), 27.3 (CH2), 27.5 (CH2), 125.4, 125.8, 126.0 (d, J = 11.9 Hz), 126.3, 126.8, 128.1, 128.3 
(CH), 130.5, 131.6 (C), 132.3 (CH), 132.5 (C), 133.0 (CH), 134.1 (C), 134.1 (CH), 136.0, 
136.3, 141.2, 141.3, 142.0, 148.2 (C), 182.2, 182.6 (CO). IR (KBr, cm1):  = 2962, 2849 (w), 
1665 (s), 1630 (w), 1589 (m), 1572, 1512, 1478, 1470, 1454, 1434, 1409, 1392, 1358 (w), 
1325, 1313 (m), 1294, 1288, 1262 (s), 1210, 1189, 1163, 1156 (m), 1114, 1089 (w), 1073 (m), 
1051, 1041, 1017, 974 (w), 951, 943 (m), 889 (w), 871 (m), 832 (s), 791 (m), 761, 738 (w), 
712 (s), 694, 669, 648, 583, 553, 533 (m). GC-MS (EI, 70 eV): m/z (%) = 416 ([M]+, 30), 388 
(30), 387 (100), 372 (5), 357 (4). HRMS (EI, 70 eV): calcd for C30H24O2 [M]+: 416.17708, 
found 416.176631.
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1-(4-Trifluoromethylphenyl)-2-trifluoromethylsulfonyloxy)anthraquinone (190a)
Starting with 187 (250 mg, 0.5 mmol), 188a (95 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (160 mg, 0.75 mmol) 
and 1,4-dioxane (3 mL), 190a was isolated as a yellow solid (186 mg, 
74%), mp 135-136 oC. 1H NMR (300 MHz, CDCl3):  = 7.29 (d, J = 
8.24 Hz, 2H, ArH), 7.64-7.71 (m, 5H, ArH), 7.94-7.96 (m, 1H, ArH), 
8.14-8.17 (m, 1H, ArH), 8.43 (d, J = 8.57 Hz, 1H, ArH). 13C NMR 
(75.4 MHz, CDCl3):  = 117.0 (q, JF,C = 321.0 Hz, CF3), 123.1 (q, JF,C = 271.3 Hz, CF3), 124.3 
(q, J = 272.0 Hz), 125.4, 126.0, 126.5, 128.1, 129.1 (CH), 129.2, 129.6, 131.1, 132.2, 133.0 (d, 
J = 1.7 Hz, C), 133.4, 133.7 (CH), 134.7, 136.7 (d, J = 1.1 Hz), 151.1 (C), 180.4, 180.8 (CO). 
19F NMR (282 MHz, CDCl3):  = -74.03 (s, 3F, CF3), -62.57 (s, 3F, CF3). IR (KBr, cm1):  = 
1674 (s), 1617, 1589, 1572, 1479, 1452, 1433, 1418 (w), 1402 (m), 1326 (s), 1301, 1273 (m), 
1249 (w), 1219, 1165, 1125, 1107, 1085, 1061 (s), 1018 (m), 1000 (w), 946 (m), 793, 770, 743 
(w), 723, 711 (s), 676, 651 (w), 601 (s), 572, 528 (m). GC-MS (EI, 70 eV): m/z (%) = 500 
([M]+, 48), 499 (13), 431 (25), 368 (24), 367 (100), 366 (24), 298 (23). HRMS (EI, 70 eV): 
calcd for C22H10O5F6S1 [M]+: 500.01476, found 500.013920.
1-(4-Methoxyphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (190b)
Starting with 187 (250 mg, 0.5 mmol), 188b (76 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (160 mg, 0.75 mmol) 
and 1,4-dioxane (3 mL), 190b was isolated as an orange crystal (154 
mg, 67%), mp 140-142 oC. 1H NMR (300 MHz, CDCl3):  = 3.82 (s, 
3H, OCH3), 6.94 (d, J = 8.76 Hz, 2H, ArH), 7.07 (d, J = 8.76 Hz, 2H, 
ArH), 7.60-7.67 (m, 3H, ArH), 7.96-8.00 (m, 1H, ArH), 8.11-8.14 (m, 
1H, ArH), 8.36 (d, J = 8.67 Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 55.2 (OCH3), 
113.8, (CH), 118.2 (q, JF,C = 320.4 Hz, CF3), 125.4 (C), 126.2, 126.8, 127.5, 129.2, 130.0 (CH), 
132.3, 133.5 (C), 134.0 (CH), 134.1, 134.5 (C), 134.6 (CH), 137.3, 152.0, 159.6 (C), 182.0, 
182.1 (CO). 19F NMR (282 MHz, CDCl3):  = -74.04 (s, 3F, CF3). IR (KBr, cm1):  = 2838 
(w), 1671 (s), 1606 (m), 1588, 1550, 1516, 1464, 1451, 1440 , 1412, 1394 (w), 1328, 1311 (m), 
1297, 1240 (s), 1208, 1107, 1088, 1074 (m), 1027 (s), 977 (w), 954 (s), 858 (w), 840 (m), 828 
(s), 811 (w), 800 (s), 767, 749 (w), 727, 718 (s), 697 (m), 669, 649 (w), 640, 601, 588 (m), 537 
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(s). GC-MS (EI, 70 eV): m/z (%) = 462 ([M]+, 55), 330 (23), 329 (100), 314 (17), 286 (11), 202 
(14). HRMS (EI, 70 eV): calcd for C22H13O6F3S1 [M]+: 462.03794, found 462.037734.
1-(4-tert-Butylphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (190c)
Starting with 187 (250 mg, 0.5 mmol), 188c (90 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (160 mg, 0.75 mmol) 
and 1,4-dioxane (3 mL), 190c was isolated as a yellow crystal (149 mg, 
61%), mp 160-162 oC. 1H NMR (250 MHz, CDCl3):  = 1.31 (s, 9H, 
3CH3), 7.07 (d, J = 8.4 Hz, 2H, ArH), 7.42 (d, J = 8.51 Hz, 2H, ArH), 
7.58-7.67 (m, 3H, ArH), 7.96-8.0 (m, 1H, ArH), 8.11-8.14 (m, 1H, 
ArH), 8.36 (d, J = 8.81 Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 31.3 (3CH3), 34.7 
(C), 118.2 (q, JF,C = 318.5 Hz, CF3), 125.2, 126.3, 126.9, 127.7, 128.3, 129.3 (CH), 130.5, 
132.4, 133.4 (C), 134.1 (CH), 134.1 (C), 134.5 (CH), 134.6, 137.6, 151.2, 151.8 (C), 181.9, 
182.0 (CO). 19F NMR (282 MHz, CDCl3):  = -74.2 (s, 3F, CF3). IR (KBr, cm1):  = 2960, 
2930, 2869, 1675, 1665, 1590, 1580, 1573, 1429 (w), 1410 (m), 1362, 1329, 1316, 1297 (w), 
1267 (m), 1205 (s), 1165 (m), 1129 (s), 1079, 1040, 1017, 997 (w), 946, 879, 843 (m), 820 (s), 
792, 775, 767, 757, 745 (w), 725 (m), 713 (s), 683, 671 (w), 642 (m), 603 (s), 573 (m). GC-MS 
(EI, 70 eV): m/z (%) = 488 ([M]+, 18), 473 (100), 431 (31), 325 (58), 299 (26), 239 (08). 
HRMS (EI, 70 eV): calcd for C25H19O5F3S [M]+: 488.08998, found 488.090070.
1-(4-Chlorophenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (190d)
Starting with 187 (250 mg, 0.5 mmol), 188d (78 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (160 mg, 0.75 mmol) 
and 1,4-dioxane (3 mL), 190d was isolated by as a yellow solid (199 
mg, 85%), mp 160-162 oC. 1H NMR (300 MHz, CDCl3):  = 7.08-7.11 
(m, 2H, ArH), 7.38-7.40 (m, 2H, ArH), 7.62-7.71 (m, 3H, ArH), 7.96-
8.00 (m, 1H, ArH), 8.14-8.17 (m, 1H, ArH), 8.41 (d, J = 8.68 Hz, 1H, 
ArH). 13C NMR (75.4 MHz, CDCl3):  = 118.1 (q, JF,C = 320.5 Hz, CF3), 126.3, 127.0, 127.6, 
128.7, 129.9, 130.0 (CH), 132.1, 132.3, 133.3, 134.1, 134.2 (C), 134.3 (CH), 134.5 (C), 134.7 
(CH), 136.1, 151.4 (C), 181.6, 182.0 (CO). 19F NMR (282 MHz, CDCl3):  = -73.92 (s, 3F, 
CF3). IR (KBr, cm1):  = 1676 (s), 1589, 1579, 1570, 1492, 1477, 1453 (w), 1408 (m), 1327, 
1314, 1300 (w), 1270 (m), 1253 (w), 1212, 1170, 1132 (s), 1089, 943 (m), 883 (s), 854 (w), 
827 (s), 793, 775 (w), 713 (s), 640 (m). GC-MS (EI, 70 eV): m/z (%) = 468 ([M+H]+, 37Cl, 21), 
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467 ([M]+, 37Cl, 14), 466 ([M+H]+, 35Cl, 53), 465 ([M]+, 35Cl, 09), 431 (09), 335 (32), 334 (25), 
333 (100), 332 (14), 298 (35), 297 (15), 270 (19). HRMS (EI, 70 eV): calcd for 
C21H10Cl1F3O5S1 ([M]+, 35Cl): 465.98841, found 465.987508.
1-(3-Trifluoromethylphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (190e)
Starting with 187 (250 mg, 0.5 mmol), 188g (95 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (160 mg, 0.75 mmol) 
and 1,4-dioxane (3 mL), 190e was isolated as a yellow solid (209 mg, 
84%), mp 115-117 oC. 1H NMR (300 MHz, CDCl3):  = 7.35 (d, J = 
7.62 Hz, 1H, ArH), 7.42 (s, 1H, ArH), 7.52 (t, J = 7.76 Hz, 1H, ArH), 
7.60-7.73 (m, 4H, ArH), 7.89-7.92 (m, 1H, ArH), 8.08-8.10 (m, 1H, ArH), 8.38 (d, J = 8.64 
Hz, 1H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 117.0 (q, JF,C = 320.6 Hz, CF3), 123.0 (q, JF,C
= 272.2 Hz, CF3), 124.1 (q, J = 3.8 Hz), 124.6 (q, J = 3.8 Hz), 125.4, 126.0, 126.5, 127.8 (d, J
= 4.0 Hz), 129.1 (CH), 129.5, 130.0 (C), 131.2 (CH), 132.2, 133.0 (d, J = 5.5 Hz, C), 133.3 
(CH), 133.6 (C), 133.7 (d, J = 4.4 Hz, CH), 134.4, 144.0, 150.2 (C), 180.4, 180.7 (CO). 19F 
NMR (282 MHz, CDCl3):  = -74.10 (s, 3F, CF3), -62.70 (s, 3F, CF3). IR (KBr, cm1):  =
1673 (s), 1589, 1568, 1492, 1479 (w), 1418, 1308 (m), 1277, 1274 (w), 1250 (m), 1213, 1167, 
1121, 1099, 1069 (s), 1001 (w), 955 (m), 883, 839, 804 (s), 770 (w), 727, 712, 702 (s), 689, 
652 (w), 628, 598 (s), 572 (m). GC-MS (EI, 70 eV): m/z (%) = 500 ([M]+, 34), 431 (12), 368 
(21), 367 (100), 266 (16), 347 (24). HRMS (EI, 70 eV): calcd for C22H10O5F6S1 [M]+: 
500.01476, found 500.015351.
1-(3-Methoxyphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (190f)
Starting with 187 (250 mg, 0.5 mmol), 188h (76 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (160 mg, 0.75 
mmol) and 1,4-dioxane (3 mL), 190f was isolated as a yellow solid 
(183 mg, 79%), mp 115-116 oC. 1H NMR (300 MHz, CDCl3):  = 
3.72 (s, 3H, OCH3), 6.69-6.73 (m, 2H, ArH), 6.91-6.95 (m, 1H, ArH), 
7.31 (t, J = 8.76 Hz, 1H, ArH), 7.58-7.66 (m, 3H, ArH), 7.94-8.01 (m, 1H, ArH), 8.10-8.13 
(m,  1H, ArH), 8.36 (d, J = 8.70 Hz, 1H, ArH) 13C NMR (62.9 MHz, CDCl3):  = 55.2 (OCH3), 
113.8, 114.3 (CH), 118.2 (q, JF,C = 320.5 Hz, CF3), 120.8, 126.1, 126.8, 127.5, 129.4, 129.5 
(CH), 132.2, 133.3, 134.0 (C), 134.1 (CH), 134.3 (C), 134.6 (CH), 135.0, 137.1, 151.5, 159.5 
(C), 181.7, 181.8 (CO). 19F NMR (282 MHz, CDCl3):  = -74.02 (s, 3F, CF3). IR (KBr, cm1):
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 = 1679 (m), 1606, 1571, 1488, 1455 (w), 1422 (s), 1327, 1300 (w), 1270 (m), 1250 (w), 
1210, 1166, 1152, 1132 (s), 1096, 1076 (w), 1038 (m), 1000 (w), 959 (m), 892, 848 (s), 825, 
810, 780, 769 (m), 742 (w), 725 (m), 707, 701 (s), 671 (m), 627, 597 (s), 571 (m). GC-MS (EI, 
70 eV): m/z (%) = 462 ([M]+, 40), 330 (21), 329 (100), 314 (28), 298 (10), 286 (14), 202 (13). 
HRMS (EI, 70 eV): calcd for C22H13O6F3S1 [M]+: 462.03794, found 462.038112.
1-(4-Fluorophenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (190g)
Starting with 187 (250 mg, 0.5 mmol), 188i (70 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (160 mg, 0.75 mmol) 
and 1,4-dioxane (3 mL), 190g was isolated as a yellow solid (113 mg, 
50%), mp 136-138 oC. 1H NMR (300 MHz, CDCl3):  = 7.11-7.14 (m, 
4H, ArH), 7.63-7.72 (m, 3H, ArH), 7.97-8.00 (m, 1H, ArH), 8.16-8.20 
(m, 1H, ArH), 8.42 (d, J = 8.70 Hz, 1H, ArH). 13C NMR (62.9 MHz, 
CDCl3):  = 115.4, 115.7 (CH), 118.1 (q, JF,C = 318.3 Hz, CF3), 126.3, 127.0, 127.5 (CH), 
129.4 (d, JF,C = 3.7 Hz, C), 129.7, 130.4, 130.5 (CH), 132.2, 133.4, 134.1 (C), 134.2 (CH), 
134.3 (C), 134.6 (CH), 136.3, 151.5 (C), 162.7 (d, JF,C = 247.7 Hz, CF), 181.7, 182.0 (CO). 19F 
NMR (282 MHz, CDCl3):  = -113.01 (s, 1F, CF), -74.00 (s, 3F, CF3). IR (KBr, cm1):  = 
1674 (m), 1589, 1568, 1510. 1479, 1450 (w), 1420 (m), 1329, 1315, 1298, 1271, 1249 (w), 
1206 (s), 1162 (m), 1130 (s), 1096 (m), 1080, 1038, 1015, 999, 974, 945 (w), 879 (s), 856 (m), 
832, 809 (s), 770, 752 (w), 729 (m), 717, 708 (s), 681, 669 (w), 646 (m), 637, 621 (w), 603, 
578 (s), 541 (m). GC-MS (EI, 70 eV): m/z (%) = 450 ([M]+, 46), 449 (09), 318 (23), 317 (100), 
316 (14), 260 (10), 233 (20), 231 (14). HRMS (EI, 70 eV): calcd for C21H10O5F4S1 [M]+: 
450.01796, found 450.017099.
1-(4-Trifluoromethoxyphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (190h)
Starting with 187 (250 mg, 0.5 mmol), 188j (102 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (160 mg, 0.75 mmol) 
and 1,4-dioxane (3 mL), 190h was isolated as a yellow solid (135 mg, 
52%), mp 108-110 oC. 1H NMR (300 MHz, CDCl3):  = 7.17-7.28 (m, 
4H, ArH), 7.66-7.70 (m, 3H, ArH), 7.96-8.00 (m,1H, ArH), 8.16-8.18 
(m, 1H, ArH),  8.43 (d, J = 8.65 Hz, 1H, ArH). 13C NMR (75.4 MHz, 
CDCl3):  = 118.1 (q, JF,C = 320.6 Hz, CF3), 120.5 (q, JF,C = 257.6 Hz, OCF3), 120.8, 126.4, 
127.0, 127.6, 129.9, 130.1 (CH), 132.3, 133.3, 134.1, 134.2 (C), 134.3, 134.7 (CH), 135.8, 
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149.2, 149.3, 151.3 (C), 181.6, 182.0 (CO). 19F NMR (282 MHz, CDCl3):  = -74.10 (s, 3F, 
CF3), -57.78 (s, 3F, OCF3). IR (KBr, cm1):  = 1681 (m), 1609, 1588, 1570, 1510, 1450 (w), 
1425 (m), 1409, 1329, 1315, 1298 (w), 1250, 1204, 1167, 1152, 1131, 1105 (s), 1081 (m), 
1038 (w), 1019 (m), 999 (w), 946 (m), 920 (w), 877 (s), 852 (m), 820 (s), 805 (m), 771 (w), 
722, 711 (s), 681, 668, 655 (w), 628 (m), 599 (s), 571, 553, 527 (m). GC-MS (EI, 70 eV): m/z
(%) = 516 ([M]+, 43), 431 (10), 384 (22), 383 (100), 382 (13). HRMS (EI, 70 eV): calcd for 
C22H10O6F6S1 [M]+: 416.00968, found 416.010762.
3.3.2 General procedure for the synthesis of 191a-f
The reaction was carried out in a pressure tube. To a dioxane suspension (3 mL) of 187
(0.5 mmol), Ar1B(OH)2 (0.5 mmol) and Pd(PPh3)4 (3 mol-%) was added K3PO4 (0.75 mmol), 
and the resultant solution was degassed by bubbling argon through the solution for 10 min. The 
mixture was heated at 90 °C under an argon atmosphere for 10 h. The mixture was cooled to 20 
°C. Ar2B(OH)2 (0.55 mmol) , Pd(PPh3)4 (3 mol-%), K3PO4 (0.75 mmol) and dioxane (2 mL) 
were added. The reaction mixtures were heated under an argon atmosphere for 10 h at 110 °C. 
They were diluted with H2O and extracted with CH2Cl2 (3 × 25 mL). The combined organic 
layers were dried (Na2SO4), filtered and the filtrate was concentrated in vacuo. The residue was 
purified by flash chromatography (flash silica gel, heptanes/EtOAc).
1-(4-Trifluoromethylphenyl)-2-(4-tert-butylphenyl)anthraquinone (191a)
Starting with 187 (252 mg, 0.5 mmol), 188a (95 mg, 0.5 
mmol), Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4
(320 mg, 1.5 mmol), 1,4-dioxane (3 mL), and 188c (98 mg, 
0.55 mmol), 191a  was isolated as a yellow crystal (157 mg, 
65%), mp 225-227 oC. 1H NMR (300 MHz, CDCl3):  = 
1.15 (s, 9H, 3CH3), 6.76-6.80 (m, 2H, ArH), 7.03-7.10 (m, 
4H, ArH), 7.38 (d, J = 8.1 Hz, 2H, ArH), 7.61-7.66 (m, 2H, ArH), 7.70 (d, J = 8.01 Hz, 1H, 
ArH), 7.94-7.98 (m, 1H, ArH), 8.16-8.20 (m, 1H, ArH), 8.36 (d, J = 8.04 Hz, 1H, ArH). 13C
NMR (75.4 MHz, CDCl3):  = 31.2 (3CH3), 34.4 (C), 124.3 (q, JF,C = 272.3 Hz, CF3), 124.4
(dq, JF,C = 7.6, 2.2 Hz), 124.7, 126,7, 127.4, 127.6 (CH), 128.5 (q, J = 32.8 Hz, C), 129.0, 
129.7 (CH), 131.3, 132.8, 133.6 (C), 133.8, 134.3 (CH), 134.6 (C), 135.4 (CH), 136.3, 140.8, 
144.0 (d, J = 1.7 Hz,), 149.1, 150.5 (C), 183.0, 183.6 (CO). 19F NMR (282 MHz, CDCl3):  = -
62.3 (s, 3F, CF3). IR (KBr, cm1):  = 2962, 2905, 2869 (w), 1672 (m), 1613, 1588, 1552, 
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1513, 1462, 1409, 1399, 1363 (w), 1321 (s), 1300, 1278, 1263 (m), 1213, 1186 (w), 1158 (s), 
1118 (m), 1105 (s), 1087, 1075, 1059, 1016 (m), 976 (w), 954 (m), 899, 864 (w), 837, 824 (m), 
796, 784, 767, 758, 744 (w), 718 (s), 688, 671, 662, 640, 605 (w), 584 (m), 566, 564, 532 (w). 
GC-MS (EI, 70 eV): m/z (%) = 484 ([M]+, 43), 469 (100), 449 (10), 427 (08), 383 (02), 357 
(03). HRMS (EI, 70 eV): calcd for C31H23O2F3 [M]+: 484.16447, found 484.164850.
1-(4-Methoxyphenyl)-2-(4-tert-butylphenyl)anthraquinone (191b)
Starting with 187 (252 mg, 0.5 mmol), 188b (76 mg, 0.5 
mmol), Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4
(320 mg, 1.5 mmol), 1,4-dioxane (3 mL), and 188c (98 mg, 
0.55 mmol), 191b was isolated as a red solid  (111 mg, 
50%), mp 221-222 oC. 1H NMR (300 MHz, CDCl3):  = 
1.18 (s, 9H, 3CH3), 3.71 (s, 3H, OCH3), 6.70 (d, J = 8.58 
Hz, 2H, ArH), 6.84 (d, J = 7.26 Hz, 4H, ArH), 7.10 (d, J = 8.58 Hz, 2H, ArH), 7.58-7.68 (m, 
3H, ArH), 7.98-8.01 (m, 1H, ArH), 8.16-8.20 (m, 1H, ArH), 8.32 (d, J = 8.58 Hz, 1H, ArH). 
13C NMR (62.9 MHz, CDCl3):  = 30.2 (3CH3), 33.4 (C), 54.0 (OCH3), 112.1, 123.5, 125.4, 
125.9, 126.3, 128.1, 129.4 (CH), 130.8, 130.9, 131.7 (C), 132.4 (CH), 132.6 (C), 133.0 (CH), 
134.1 (C), 134.2 (CH), 136.1, 141.0, 148.3, 149.0, 157.2 (C), 182.3, 183.0 (CO). IR (KBr, 
cm1):  = 2956, 2865, 2839, 2042, (w), 1671 (s), 1658, 1609, 1586 (w), 1573 (m), 1547 (w), 
1513 (m), 1477, 1465, 1451, 1439, 1415, 1405, 1390, 1361 (w), 1329, 1315 (m), 1297, 1277, 
1241 (s), 1206 (m), 1176 (s), 1159, 1115 (m), 1088, 1071 (w), 1024 (s), 1014 (m), 977 (w), 953 
(m), 941, 931, 901, 859, (w), 836 (m), 823 (s), 795 (m), 767, 752, 747 (w), 718 (s), 686, 661 
(w), 648 (m), 634 (w), 597, 578, 569 (m), 540 (s). GC-MS (EI, 70 eV): m/z (%) = 446 ([M]+, 
100), 445 (12), 432 (16), 431 (40), 416 (10), 415 (23), 390 (13). 389 (18), HRMS (EI, 70 eV): 
calcd for C31H26O3 [M]+: 446.18765, found 446.187401.
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1-(4-tert-Butylphenyl)-2-(4-trifluoromethylphenyl)anthraquinone (191c)
Starting with 187 (252 mg, 0.5 mmol), 188c (90 mg, 0.5 mmol), 
Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (320 mg, 1.5
mmol),  1,4-dioxane (3 mL), and 188a (104 mg, 0.55 mmol), 
191c was isolated as a yellow solid (143 mg, 60%), mp 220-222 
oC. 1H NMR (300 MHz, CDCl3):  = 1.20 (s, 9H, 3CH3), 6.81 
(d, J = 8.59 Hz, 2H, ArH), 6.98 (d, J = 8.12 Hz, 2H, ArH), 7.14 
(d, J = 8.59 Hz, 2H, ArH), 7.28 (d, J = 8.12 Hz, 2H, ArH), 7.60-7.68 (m, 3H, ArH), 8.00-8.02 
(m, 1H, ArH), 8.17-8.20 (m, 1H, ArH), 8.36 (d, J = 8.12 Hz, 1H, ArH). 13C NMR (75.4 MHz, 
CDCl3):  = 30.2 (3CH3), 33.4 (C), 122.9 (q, J = 272.2 Hz, CF3), 123.3 (q, JF,C = 7.4, 3.7 Hz), 
123.5, 125.6, 126.1, 126.5 (CH), 127.7 (C), 127.8 (CH), 128.2 (C), 128.7 (CH), 130.4, 131.7 
(C), 132.6, 133.2, 133.6 (CH), 133.8, 135.1, 141.5, 142.8 (d, J = 1.3 Hz), 146.9, 148.7 (C), 
182.1, 182.4 (CO). 19F NMR (282 MHz, CDCl3):  = -62.68 (s, 3F, CF3). IR (KBr, cm1):  =
1674 (s), 1615, 1587, 1576, 1551, 1511, 1461, 1456, 1415, 1393, 1364, 1359 (w), 1323, 1300 
(s), 1283, 1258 (m), 1210, 1198, 1184 (w), 1155, 1109 (s), 1085 (m), 1073, 1061, 1014 (s), 
978, 967 (w), 956, 941 (m), 903, 861 (m), 837, 823 (s), 796 (m), 780, 766, 753, 739 (w), 720, 
714, 700 (s), 678 (w), 646 (m), 632 (w), 605, 585, 563, 545 (m). GC-MS (EI, 70 eV): m/z (%) 
= 485 ([M+H]+, 10), 484 ([M]+, 29), 470 (34), 469 (100), 428 (22), 427 (65). HRMS (EI, 70 
eV): calcd for C31H24F3O2 [M+H]+: 485.1723, found 485.1713.
1-(4-Chlorophenyl)-2-(4-tert-butylphenyl)anthraquinone (191d)
Starting with 187 (252 mg, 0.5 mmol), 188d (78 mg, 0.5 
mmol), Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4
(320 mg, 1.5 mmol),  1,4-dioxane (3 mL), and 188c (98 mg, 
0.55 mmol), 191d was isolated as a yellow solid (137 mg, 
61%), mp 245-246 oC. 1H NMR (300 MHz, CDCl3):  = 
1.30 (s, 9H, 3CH3), 6.92-7.00 (m, 4H, ArH), 7.21-7.26 (m, 
4H, ArH), 7.75-7.82 (m, 3H, ArH), 8.09-8.12 (m, 1H, ArH), 8.30-8.33 (m, 1H, ArH), 8.48 (d, J
= 7.46 Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 31.2 (3CH3), 34.5 (C), 124.7, 126.6, 
127.3, 127.4, 128.0, 129.1, 130.7 (CH), 131.6, 132.5, 132.7, 133.6 (C), 133.7, 134.2 (CH), 
134.8 (C), 135.5 (CH), 136.6, 138.4, 141.0, 149.1, 150.3 (C), 183.1, 183.8 (CO). IR (KBr, 
cm1):  = 1667 (s), 1588, 1575, 1549, 1513, 1492, 1477, 1461, 1409, 1391, 1360 (w), 1332 
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(m), 1316 (w), 1298 (m), 1277 (w), 1261 (m), 1247, 1212, 1184, 1159, 1112, 1087, 1071 (w), 
1013 (m), 981 (w), 954 (m), 941, 905, 858, 842 (w), 832, 825 (m), 794, 774, 763, 746 (w), 720 
(s), 697, 691, 679, 643, 630 (w), 583, 576 (m), 549, 533 (w). GC-MS (EI, 70 eV): m/z (%) = 
452 ([M]+, 37Cl, 16), 451 ([M+H]+, 35Cl, 19), 450 ([M]+, 35Cl, 46), 437 (38), 436 (31), 435 
(100), 393 (14), 207 (10).  HRMS (EI, 70 eV): calcd for C30H24CllO2 ([M+H]+, 35Cl): 
451.1459, found 451.1459.
1-(3-Trifluoromethylphenyl)-2-(4-trifluoromethylphenyl)anthraquinone (191e)
Starting with 187 (252 mg, 0.5 mmol), 188g (95 mg, 0.5 
mmol), Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4 (320 
mg, 1.5 mmol), 1,4-dioxane (3 mL), and 188a (104 mg, 0.55 
mmol), 191e was isolated as a yellow solid (169 mg, 68%), mp 
255-256 oC. 1H NMR (300 MHz, CDCl3):  = 7.02 (d, J = 8.23 
Hz, 2H, ArH), 7.14 (d, 7.65 Hz, 1H, ArH), 7.27-7.45 (m, 5H, ArH), 7.65-7.77 (m, 3H, ArH), 
8.00-8.03 (m, 1H, ArH), 8.23-8.26 (m, 1H, ArH), 8.46 (d, J = 8.10 Hz, 1H, ArH). 13C NMR 
(62.9 MHz, CDCl3):  = 122.8 (q, JF,C = 321.2 Hz, CF3), 123.1 (q, JF,C =  272.0 Hz, CF3), 
123.6 (d, J = 4.1 Hz), 124.8 (d, J = 3.7 Hz), 126.2 (d, J = 3.8 Hz), 126.8, 127.4, 127.8, 128.2, 
129.7 (CH), 130.0, 130.5, 131.5 (C), 132.5 (CH), 132.6 (C), 134.0 (CH), 134.3 (C), 134.4 
(CH), 134.6 (C), 134.9 (CH), 140.1, 140.5, 143.0, 147.6 (C) 182.8, 183.3 (CO). 19F NMR (282 
MHz, CDCl3):  = -62.79 (s, 3F, CF3), -62.78 (s, 3F, CF3). IR (KBr, cm1):  = 1669 (s), 1617, 
1589, 1574, 1533, 1490, 1432, 1414, 1399 (w), 1328, 1302 (s), 1285, 1263, 1244, 1291, 1212 
(w), 1161, 1109, 1081, 1066 (s), 1018 (m), 1002, 981 (w), 961 (m), 923, 893, 863 (w), 849 
(m), 836 (w), 825, 805 (m), 792, 767, 752, 746, 725 (w), 712, 706 (s), 686 (w), 675 (m), 655, 
629, 605, 567, 542 (w). GC-MS (EI, 70 eV): m/z (%) = 496 ([M]+, 80), 495 (100), 477 (09), 
428 (21). 427 (72), 407 (08). HRMS (EI, 70 eV): calcd for C28H13O2F6 [M-H]+: 495.08143, 
found 495.080798.  
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1-(3-Trifluoromethylphenyl)-2-(4-tert-butylphenyl)anthraquinone (191f)
Starting with 187 (252 mg, 0.5 mmol), 188g (95 mg, 0.5 
mmol), Pd(PPh3)4 (17 mg, 3 mol-%, 0.015 mmol), K3PO4
(320 mg, 1.5 mmol), 1,4-dioxane (3 mL), and 188c (98 mg, 
0.55 mmol), 191f was isolated as a yellow solid (148 mg, 
61%), mp 227-229 oC. 1H NMR (300 MHz, CDCl3):  = 
1.16 (s, 9H, 3CH3), 6.75 -6.77 (m, 2H, ArH), 7.07-7.10 (m, 3H, ArH), 7.17 (d, J = 8.34 Hz, 
1H, ArH), 7.27 (t, J = 7.68 Hz, 1H, ArH), 7.40 (d, J = 7.86 Hz, 1H, ArH), 7.60-7.70 (m, 2H, 
ArH), 7.73 (d, J = 7.86 Hz, 1H, ArH), 7.96-8.00 (m, 1H, ArH), 8.18-8.21 (m, 1H, ArH), 8.37 
(d, J = 8.04 Hz, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 30.1 (3CH3), 33.4 (C), 122.2 (q, 
JF,C  = 3.84 Hz, CH), 122.9 (q, J = 272.4 Hz, CF3), 123.6, 125.3 (q, J = 3.8 Hz), 125.6, 126.3, 
126.5, 126.7, 128.0 (CH), 128.7, 129.1, 130.4, 131.7 (C), 131.9 (CH), 132.6 (C), 132.7, 133.2 
(CH), 133.7 (C), 134.2 (CH), 135.2, 139.6 (d, J = 9.8 Hz), 148.3, 149.4 (C), 182.0, 182.6 (CO). 
19F NMR (282 MHz, CDCl3):  = -62.68 (s, 3F, CF3). IR (KBr, cm1):  = 2957, 2907, 2872, 
2134 (w), 1671 (s), 1589, 1574, 1549, 1513, 1479, 1460, 1433, 1407, 1393, 1365 (w), 1329, 
1316, 1302 (s), 1279 (m), 1258, 1245 (s), 1211, 1183 (w), 1159, 1116, 1100, 1068 (s), 1017 
(m), 1001, 986, 973 (w), 961 (m), 917, 892 (w), 861, 838 (m), 824, 801 (s), 792 (m), 768, 751, 
744 (w), 715, 702 (s), 688 (w), 679, 666, 652 (m), 628 (w), 580, 566, 545 (m). GC-MS (EI, 70 
eV): m/z (%) = 484 ([M]+, 43), 470 (33), 469 (100). HRMS (EI, 70 eV): calcd for C31H23O2F3
[M]+: 484.16447, found 484.164011.
3.4 Synthesis of 1,2,4-Tris(trifluoromethylsulfonyloxy)anthraquinone (193)
To a solution of 1,2,4-trihydroxyanthraquinone (192) (1.0 equiv) in CH2Cl2 (10 
mL/mmol) was added pyridine (7.0 equiv) at room temperature under an argon atmosphere. 
After 10 min, Tf2O (5.0 equiv) was added at -78 °C. The mixture was allowed to warm up to 
room temperature and stirred for overnight. The reaction mixture was filtered and the filtrate 
was concentrated in vacuo. The products of the reaction mixture were isolated by rapid column 
chromatography (flash silica gel, heptane/EtOAc).
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1,2,4-Tris(trifluoromethylsulfonyloxy)anthraquinone (193)
Starting with 1,2,4-trihydroxyanthraquinone 192 (1.00 g, 3.90 mmol), 
pyridine (2.2 mL, 27.3 mmol), CH2Cl2 (40 mL), Tf2O (3.3 mL, 19.5
mmol), 193 was isolated as a yellow solid (1.10 g, 43%), mp 162-164 
oC. 1H NMR (300 MHz, CDCl3):  = 7.66 (s, 1H, ArH), 7.80-7.86 (m, 
2H, ArH), 8.22-8.36 (m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 118.3 (d, JF,C = 313.5 
Hz, CF3), 118.4 (d, JF,C = 316.0 Hz, CF3), 118.6 (d, JF,C = 319.0 Hz, CF3), 123.3 (CH), 126.8 
(C), 127.7, 127.8 (CH), 129.6, 132.5, 132.6 (C), 135.5, 135.6 (CH), 138.9, 144.5, 146.6 (C), 
178.4, 179.9 (CO). 19F NMR (282 MHz, CDCl3):   = -73.02 (q, JF = 2.82, 5.28 Hz, 3F, CF3), -
72.83 (s, 3F, CF3), -72.24 (q, JF = 2.73, 5.07 Hz, 3F, CF3). IR (KBr, cm1):   = 3100 (w), 1682 
(s), 1589 (m), 1440, 1428 (s), 1310 (m), 1278 (w), 1208, 1182, 1170, 1127 (s), 1071, 1039, 
1018 (m), 974 (w), 929, 904, 851, 812, 780, 763 (s), 756, 740 (m), 719 (s), 712, 695, 674 (m), 
653, 635 (s), 623 (m), 597, 534 (s). GC-MS (EI, 70 eV): m/z (%) = 652 ([M]+, 100), 583 (13), 
519 (11), 455 (46), 427 (16), 391 (14), 363 (85), 336 (11), 335 (74). HRMS (EI, 70 eV): calcd 
for C17H5F9O11S3 [M]+: 651.88448, found 651.883916.
3.4.1 General Procedure for Suzuki-Miyaura Reactions
A 1,4-dioxane solution (4 mL per 3 mmol of 193) of 193, K3PO4, Pd(PPh3)4 and 
arylboronic acid 188 was stirred at 110 °C or 90 °C for 10 h. After cooling to 20 °C, distilled 
water was added. The organic and the aqueous layers were separated and the latter was 
extracted with CH2Cl2. The combined organic layers were dried (Na2SO4), filtered and the 
filtrate was concentrated in vacuo. The residue was purified by column chromatography.
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1,2,4-Tris(4-trifluoromethylphenyl)anthraquinone (194a)
Starting with 193 (100 mg, 0.15 mmol), 188a (114 mg, 0.6 
mmol), Pd(PPh3)4 (17 mg, 10 mol-%, 0.015 mmol), K3PO4
(159 mg, 0.75 mmol) and 1,4-dioxane (5 mL), 194a was 
isolated as a yellow solid (43 mg, 43%),  mp 237-238 oC. 1H 
NMR (300 MHz, CDCl3):  = 7.03-7.12 (m, 4H, ArH), 7.35-
7.47 (m, 6H, ArH), 7.48 (s, 1H, ArH), 7.64-7.67 (m, 4H, ArH), 
7.94-8.02 (m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 
123.7 (q, JF,C = 272.3 Hz, CF3), 124.0 (q, JF,C = 272.1 Hz, CF3), 
124.2 (q, JF,C = 272.1 Hz, CF3), 124.9 (t, J = 3.5 Hz), 125.0, 125.2 (d, J = 3.8 Hz), 126.8, 
127.0, 128.3 (CH), 128.9 (C), 129.4, 129.6 (CH), 129.8, 130.1, 132.1, 133.4, 133.7, 133.9 (C), 
134.1, 134.2, 138.0 (CH), 140.8, 142.4, 143.0, 143.1, 145.4, 146.2 (C), 183.2, 183.7 (CO). 19F 
NMR (282 MHz, CDCl3):  = -62.77 (s, 3F, CF3), -62.41 (s, 3F, CF3), -62.38 (s, 3F, CF3). IR 
(KBr, cm1):  = 3067, 2929, 2581 (w), 1673 (m), 1616, 1592, 1531, 1407, 1372 (w), 1323 (s), 
1285, 1251 (m), 1211 (w), 1167, 1108 (s), 1089 (m), 1081, 1060, 1017 (s), 966 (m), 937, 919, 
866 (w), 839 (m), 801, 766, 746 (w), 726 (m), 711, 684, 660, 644, 622, 604, 551, 539 (w). GC-
MS (EI, 70 eV): m/z (%) = 640 ([M]+, 98), 639 (100), 638 (13), 621 (15), 572 (28), 571 (81), 
570 (36). HRMS (EI, 70 eV): calcd for C35H16F9O2 [M-H]+: 639.10011, found 639.099492.
1,2,4-Tris(4-methoxyphenyl)anthraquinone (194b)
Starting with 193 (100 mg, 0.15 mmol), 188b (91 mg, 0.6 
mmol), Pd(PPh3)4 (17 mg, 10 mol-%, 0.015 mmol), K3PO4
(159 mg, 0.75 mmol) and 1,4-dioxane (5 mL), 194b was 
isolated as an orange solid (59 mg, 73%), mp 240-242 oC. 1H 
NMR (300 MHz, CDCl3):  = 3.67 (s, 3H, OCH3), 3.74 (s, 3H, 
OCH3), 3.80 (s, 3H, OCH3), 6.61-6.64 (m, 2H, ArH), 6.72-6.75 
(m, 2H, ArH), 6.85-6.90 (m, 6H, ArH), 7.21-7.24 (m, 2H, 
ArH), 7.49 (s, 1H, ArH), 7.58-7.61 (m, 2H, ArH), 7.93-8.01 
(m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 55.0 (OCH3), 55.1 (OCH3), 55.2 (OCH3), 
113.2, 113.3, 113.6, 126.5, 126.6, 129.3, 130.5, 130.7 (CH), 131.3, 132.1, 132.2 (C), 133.5, 
133.6 (CH), 134.0, 134.3, 134.4, 134.5 (C), 138.8 (CH), 141.2, 143.3, 147.5, 158.2, 158.6, 
158.9 (C), 184.1, 185.0 (CO). IR (KBr, cm1):  = 3318, 3068, 3033, 3012, 2952, 2918, 2849, 
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2833, 2539 (w), 1665, 1606 (s), 1592, 1575 (m), 1508 (s), 1461, 1454, 1435 (m), 1410, 1368
(w), 1330, 1310 (m), 1289, 1239, 1173 (s), 1107, 1085, 1076 (m), 1027, 1010, 963 (s), 938 
(m), 917, 907, 862 (w), 829, 802, 796 (s), 773, 763 (m), 749 (w), 736 (m), 722 (s), 686 (w), 
653, 645, 628, 621 (m), 594 (w), 572 (m), 548 (s). GC-MS (EI, 70 eV): m/z (%) = 526 ([M]+, 
100), 525 (40), 495 (15), 285 (12). HRMS (EI, 70 eV): calcd for C35H26O5 [M]+: 526.17748, 
found 526.176367.
1,2,4-Tris(4-tert-butylphenyl)anthraquinone (194c)
Starting with 193 (100 mg, 0.15 mmol), 188c (107 mg,  0.6 
mmol), Pd(PPh3)4 (17 mg, 10 mol-%, 0.015 mmol), K3PO4
(159 mg, 0.75 mmol) and 1,4-dioxane (5 mL), 194c was 
isolated as an orange solid (77 mg, 83%), mp 244-246 oC. 
1H NMR (300 MHz, CDCl3):  = 1.13 (s, 9H, 3CH3), 1.20 
(s, 9H, 3CH3), 1.31 (s, 9H, 3CH3), 6.75-6.76 (m, 2H, ArH), 
6.84-6.87 (m, 2H, ArH), 6.99-7.02 (m, 2H, ArH), 7.12-7.15 
(m, 2H, ArH), 7.21-7.24 (m, 2H, ArH), 7.36-7.39 (m, 2H, 
ArH), 7.53 (s, 1H, ArH), 7.55-7.58 (m, 2H, ArH), 7.93-8.03 (m, 2H, ArH). 13C NMR (62.9 
MHz, CDCl3):  = 31.2 (CH3), 31.4 (CH3), 31.5 (CH3), 34.3, 34.4, 34.6, 124.2, 124.4, 125.0, 
126.6, 126.8, 127.7, 127.9, 128.6 (C), 129.0 (CH), 131.4 (C), 133.5, 133.5 (CH), 133.6, 134.0, 
134.4, 136.8, 137.1 (C), 138.8 (CH), 139.3, 142.0, 143.7, 148.2, 149.1, 149.8 (C), 184.1, 184.6 
(CO). IR (KBr, cm1):  = 2952 (s), 2902, 2864 (m), 1677, 1669 (s), 1607 (w), 1592 (m), 1574, 
1512, 1504, 1475 (w), 1462 (m), 1440, 1392 (w), 1360 (m), 1327 (s), 1309, 1301, 1279, 1266 
(m), 1241 (s), 1212, 1201, 1165, 1155 (w), 1114, 1081, 1016, 966 (m), 944, 934, 918, 898, 863 
(w), 831 (s), 796 (m), 772, 764, 740 (w), 725 (s), 705, 681 (w), 651, 625 (m), 615 (w), 580 (m), 
567 (s), 551 (m). GC-MS (EI, 70 eV): m/z (%) = 604 ([M]+, 31), 590 (11), 589 (24), 548 (14), 
547 (33), 532 (03), 490 (04), 287 (11), 69 (06), 57 (100). HRMS (EI, 70 eV): calcd for 
C44H44O2 [M]+: 604.33358, found 604. 33345.
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1,2,4-Tris(4-chlorophenyl)anthraquinone (194d)
Starting with 193 (100 mg, 0.15 mmol), 188d (94 mg, 0.6 mmol), 
Pd(PPh3)4 (17 mg, 10 mol-%, 0.015 mmol), K3PO4 (159 mg, 0.75 
mmol) and 1,4-dioxane (5 mL), 194d was isolated as a yellow 
solid (50 mg, 60%), mp 293-295 oC. 1H NMR (300 MHz, 
CDCl3):  = 6.84-6.92 (m, 4H, ArH), 7.07-7.11 (m, 2H, ArH), 
7.18-7.23 (m, 4H, ArH), 7.34-7.38 (m, 2H, ArH), 7.44 (s, 1H, 
ArH), 7.62-7.65 (m, 2H, ArH), 7.93-8.01 (m, 2H, ArH). 13C
NMR (75.4 MHz, CDCl3):  = 126.7, 126.8, 128.2, 128.2, 128.4, 
129.3, 130.5, 130.6 (CH), 131.9, 132.9, 133.5, 133.7, 133.8 (C), 133.9, 134.0 (CH), 134.1, 
137.5, 138.0 (C), 138.3 (CH), 141.2, 140.2, 140.7, 142.9, 145.5 (C), 183.8, 184.1 (CO). IR 
(KBr, cm1):  = 3320, 3065, 2923, 2853 (w), 1670 (s), 1650, 1644, 1632 (w), 1591 (m), 1524 
(w), 1492 (s), 1470, 1441, 1397, 1370 (w), 1328 (m), 1311 (s), 1282 (m), 1247 (s), 1209, 1158 
(w), 1089, 1013, 962 (s), 935, 918, 862 (w), 818 (s), 810, 766 (m), 733 (s), 718 (m), 700, 687, 
671, 656 (w), 647 (m), 636, 618, 593 (w), 551 (m). GC-MS (EI, 70 eV): m/z (%) = 542 ([M]+, 
2x 37Cl, 29), 541 ([M+H]+, 37Cl, 50), 540 ([M]+, 37Cl, 92), 539 ([M+H]+, 35Cl, 100), 538 ([M]+, 
35Cl, 93), 537 (78), 505 (24), 504 (26), 503 (37), 502 (25). HRMS (EI, 70 eV): calcd for 
C32H17Cl3O2 ([M]+, 37Cl): 540.02591, found 540.024908, C32H17Cl3O2 ([M]+, 2x 37Cl): 
542.02296, found 542.023142.
1,2,4-Tris(4-fluorophenyl)anthraquinone (194e)
Starting with 193 (100 mg, 0.15 mmol), 188i (84 mg, 0.6 mmol), 
Pd(PPh3)4 (17 mg, 10 mol-%, 0.015 mmol), K3PO4 (159 mg, 0.75 
mmol) and 1,4-dioxane (5 mL), 194e was isolated as an orange 
crystal (43 mg, 57%), mp 204-206 oC.1H NMR (300 MHz, 
CDCl3):  = 6.77-6.83 (m, 2H, ArH), 6.86-6.93 (m, 6H, ArH), 
7.04-7.11 (m, 2H, ArH), 7.23-7.27 (m, 2H, ArH), 7.47 (s, 1H, 
ArH), 7.61-7.64 (m, 2H, ArH), 7.93-8.01 (m, 2H, ArH). 13C NMR 
(62.9 MHz, CDCl3):  = 114.7, 114.8, 115.0, 115.1, 115.2, 115.3, 
126.6, 126.8, 129.6, 129.7, 130.7, 130.8, 131.0, 131.1 (CH), 131.8, 133.8 (C), 133.8, 133.9 
(CH), 133.9, 134.2, 135.2 (d, J = 3.3 Hz), 135.5 (d, J = 3.6 Hz), 137.7 (d, J = 3.6 Hz, C), 138.5 
(CH), 140.9, 143.0, 146.9, 161.7 (d, JF,C = 246.4 Hz), 161.9 (d, JF,C = 248.0 Hz), 162.2 (d, JF,C
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= 246.6 Hz, CF), 183.7, 184.3 (CO). 19F NMR (282 MHz, CDCl3):  = -115.07 (s, F, CF), -
114.85 (s, F, CF), -114.14 (s, F, CF). IR (KBr, cm1):  = 3069, 3041, 2920, 2852 (w), 1673 
(s), 1604 (w), 1592 (m), 1530 (w), 1510 (s), 1442, 1402, 1370 (w), 1328, 1308 (m), 1278 (w), 
1245 (m), 1222, 1157 (s), 1092, 1083, 1073, 1014 (w), 963 (m), 945, 927, 866 (w), 829, 817 
(s), 804 (m), 786, 766, 745 (w), 734, 721 (m), 709, 701, 686, 658, 650, 642, 624, 617, 587, 560 
(w), 551 (m), 534 (w). GC-MS (EI, 70 eV): m/z (%) = 490 ([M]+, 83), 489 (100), 488 (18), 394 
(18). HRMS (EI, 70 eV): calcd for C32H17O2F3 [M+]: 490.11752, found 490.116052.
1,2,4-Tris(phenyl)anthraquinone (194f)
Starting with 193 (100 mg, 0.15 mmol), 188k (73 mg, 0.6 mmol), 
Pd(PPh3)4 (17 mg, 10 mol-%, 0.015 mmol), K3PO4 (159 mg, 0.75 
mmol) and 1,4-dioxane (5 mL), 194f was isolated as a yellow solid 
(58 mg, 86%), mp 228-230 oC. 1H NMR (300 MHz, CDCl3):  = 
6.92-7.00 (m, 4H, ArH), 7.06 (t, J = 2.61 Hz, 3H, ArH), 7.16-7.18 
(m, 3H, ArH), 7.28-7.38 (m, 5H, ArH), 7.52 (s, 1H, ArH), 7.57-7.60 
(m, 2H, ArH), 7.93-8.01 (m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 126.5, 126.6, 126.8, 
127.1, 127.2, 127.6, 127.7, 128.0, 128, 129.3, 129.4 (CH), 131.6 (C), 133.6, 133.7 (CH), 133.8, 
133.9, 134.4 (C), 138.6 (CH), 139.6, 139.9, 141.8, 142.2, 143.8, 147.7 (C), 183.8, 184.5 (CO). 
IR (KBr, cm1):  = 3329, 3065, 3054, 3022, 2953, 2919, 2850 (w), 1677 (s), 1633 (w), 1590 
(m), 1557, 1537, 1524, 1494, 1455, 1443, 1431, 1370 (w), 1322, 1302 (s), 1277 (m), 1243 (s), 
1206, 1160 (w), 1085, 1077, 1071 (m), 1034 (w), 1024 (m), 1001, 975 (w), 959 (m), 938, 915, 
899, 857, 842, 825 (w), 801, 774, 760, 750, 742 (m), 728 (s), 711 (m), 691 (s), 671 (m), 652 
(s), 637, 614, 570 (m), 554 (w), 541 (s). GC-MS (EI, 70 eV): m/z (%) = 436 ([M]+, 78), 435 
(100), 434 (18), 358 (19), 218 (19), 217 (44). HRMS (EI, 70 eV): calcd for C32H19O2 [M-H]+: 
435.13796, found 435.137591.
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1,4-Bis(4-trifluoromethylphenyl)-2(trifluoromethylsulfonyloxy)anthraquinone (195a)
Starting with 193 (100 mg, 0.15 mmol), 188a (57 mg, 0.3 mmol), 
Pd(PPh3)4 (10 mg, 6 mol-%, 0.009 mmol), K3PO4 (96 mg, 0.45 mmol) 
and 1,4-dioxane (4 mL), 195a was isolated as an orange solid (61 mg, 
61%), mp 168-170 oC. 1H NMR (300 MHz, CDCl3):  = 7.32-7.40 (m, 
4H, ArH), 7.48 (s, 1H, ArH), 7.66-7.72 (m, 6H, ArH), 7.94-8.00 (m, 
2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 118.0 (q, JF,C = 320.4 Hz, 
CF3), 119.7 (q, JF,C = 272.2 Hz, CF3), 125.4 (t, J = 3.8 Hz), 127.0, 
127.1, 128.1 (CH), 128.5 (q, JF,C = 286.2 Hz, CF3), 128.9, 129.2 (CH), 
129.9, 130.2, 130.4, 132.2, 133.2, 133.3 (C), 134.5, 134.6 (CH), 135.3, 135.7, 137.7, 143.9, 
145.6, 149.6 (C), 182.2, 182.2 (CO). 19F NMR (282 MHz, CDCl3):  = -73.86 (s, 3F, CF3), -
62.59 (s, 3F, CF3), -62.51 (s, 3F, CF3). IR (KBr, cm1):  = 2917 (w), 1675 (m), 1618, 1591, 
1541, 1428, 1408 (w), 1321 (s), 1241 (m), 1217 (s), 1190 (w), 1163 (m), 1122, 1108, 1080, 
1059 (s), 1040 (w), 1017, 948, 900 (m), 854 (w), 834, 823, 799, 786, 763, 753, 744 (s), 731 
(m), 713, 692, 682, 662, 641, 630 (w), 599 (s), 571, 535 (w). GC-MS (EI, 70 eV): m/z (%) = 
644 ([M]+, 100), 643 (68), 625 (11), 576 (14), 575 (48), 512 (21), 511 (56), 510 (29), 509 (13). 
HRMS (EI, 70 eV): calcd for C29H13F9O5S1 [M]+: 644.03345, found 644.03239.
1,4-Bis(4-tert-butylphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (195b)
Starting with 193 (100 mg, 0.15 mmol), 188c (54 mg, 0.3 mmol), 
Pd(PPh3)4 (10 mg, 6 mol-%, 0.009 mmol), K3PO4 (96 mg, 0.45 mmol) 
and 1,4-dioxane (4 mL), 195b was isolated as a yellow solid (77 mg, 
81%), mp 245-247 oC.1H NMR (300 MHz, CDCl3):  = 0.59 (s, 9H, 
3CH3), 0.60 (s, 9H, 3CH3), 6.37-6.40 (m, 2H, ArH), 6.46-6.48 (m, 2H, 
ArH), 6.68-6.74 (m, 4H, ArH), 6.74 (s, 1H, ArH), 6.86-6.90 (m, 2H, 
ArH), 7.21-7.27 (m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 31.3
(3CH3), 31.4 (3CH3), 34.7, 34.8 (C), 117.5 (q, JF,C = 318.5 Hz, CF3), 
125.2, 125.3, 126.8, 127.0, 127.6, 128.3, 129.5 (CH), 130.8, 132.3, 133.7, 133.8 (C), 133.9, 
134.0 (CH), 135.5, 136.5, 137.5, 146.5, 150.1, 150.8, 151.0 (C), 182.8, 182.9 (CO). 19F NMR 
(282 MHz, CDCl3):   = -74.69 (s, 3F, CF3). IR (KBr, cm1):   = 2965 (m), 2867 (w), 1677 (s), 
1590, 1536, 1531, 1513, 1462 (w), 1425 (s), 1404, 1360 (w), 1319 (s), 1268 (m),  1239, 1214 
(s), 1177 (m), 1159 (w), 1137, 1115 (s), 1040, 1015, 1004, 977, 966 (w), 947, 900, 844, 825, 
O
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812, 803 (s), 776 (w), 746 (m), 732, 722 (s), 699 (w), 686 (m), 661 (w), 642 (m), 608 (s), 597 
(m), 566 (s), 528 (m). GC-MS (EI, 70 eV): m/z (%) = 620 ([M]+, 06), 606 (13), 605 (34), 565 
(10), 564 (32), 563 (100), 571 (09), 457 (10). HRMS (EI, 70 eV): calcd for C35H31F3O5S [M]+: 
620.18388, found 620.183785.
1,4-Bis(4-methyllphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (195c)
Starting with 193 (100 mg, 0.15 mmol), 188e (41 mg, 0.3 mmol), 
Pd(PPh3)4 (10 mg, 6 mol-%, 0.009 mmol), K3PO4 (96 mg,  0.45 mmol) 
and 1,4-dioxane (4 mL), 195c was isolated as a yellow solid (42 mg, 
51%), mp 186-188 oC.1H NMR (300 MHz, CDCl3):  = 2.39 (s, 3H, 
CH3), 2.40 (s, 3H, CH3), 7.07-7.10 (m, 2H, ArH), 7.14-7.17 (m, 2H, 
ArH), 7.22-7.26 (m, 4H, ArH), 7.46 (s, 1H, ArH), 7.59-7.66 (m, 2H, 
ArH), 7.94-7.98 (m, 2H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 21.4
(CH3), 21.5 (CH3), 118.1 (q, JF,C = 320.7 Hz, CF3), 126.9, 127.0, 127.8, 
128.5, 129.1, 129.2, 129.3 (CH), 130.8, 132.4, 133.7, 133.8 (C), 134.0, 134.1 (CH), 135.5, 
136.7, 137.6, 137.8, 137.9, 146.5, 150.1 (C), 182.8, 182.9 (CO). 19F NMR (282 MHz, CDCl3): 
 = -73.96 (s, 3F, CF3). IR (KBr, cm1):  = 3022, 2960, 2920, 2860 (w), 1675 (s), 1651, 1592, 
1538, 1515, 1446 (w), 1420 (s), 1403, 1379 (w), 1312 (m), 1272, 1261 (w), 1239 (m), 1220, 
1205 (s), 1161 (w), 1131 (s), 1037, 1019, 1005, 962 (w), 946, 896 (s), 848 (m), 829, 819, 810, 
798 (s), 769 (w), 752 (m), 729 (s), 715 (m), 689, 659, 650, 631 (w), 599 (s), 570, 558, 538, 530 
(m). GC-MS (EI, 70 eV): m/z (%) = 536 ([M]+, 85), 535 (23), 523 (10), 522 (26), 521 (100), 
404 (10), 403 (48), 402 (33), 401 (20), 389 (18), 388 (77), 387 (61), 386 (27). HRMS (EI, 70 
eV): calcd for C29H19F3O5S1 [M]+: 536.08998, found 536.090080.
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1,4-Bis(4-ethyllphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (195d)
Starting with 193 (100 mg, 0.15 mmol), 188f (45 mg, 0.3 mmol), 
Pd(PPh3)4 (10 mg, 6 mol-%, 0.009 mmol), K3PO4 (96 mg,  0.45 mmol) 
and 1,4-dioxane (4 mL), 195d was isolated as a yellow solid (64 mg, 
74%), mp 142-144 oC. 1H NMR (300 MHz, CDCl3):  = 1.24 (t, J = 
7.62 Hz, 3H, CH3), 1.26 (t, J = 7.60 Hz, 3H, CH3), 2.70 (q, J = 15.18, 
7.59 Hz, 4H, 2CH2), 7.08-7.12 (m, 2H, ArH), 7.17-7.20 (m, 2H, ArH), 
7.24-7.28 (m, 4H, ArH), 7.47 (s, 1H, ArH), 7.60-7.63 (m, 2H, ArH), 
7.94-7.99 (m, 2H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 15.2 (CH3), 
15.3 (CH3), 28.6 (CH2), 28.7 (CH2), 118.1 (q, JF,C = 320.1 Hz, CF3), 126.9, 127.0, 127.8, 127.9, 
128.2, 128.5, 129.4 (CH), 131.0, 132.4, 133.7, 133.8 (C), 134.0, 134.1 (CH), 135.5, 136.7, 
137.8, 143.9, 144.2, 146.6, 150.1 (C), 182.8, 182.9 (CO). 19F NMR (282 MHz, CDCl3):  = -
74.01 (s, 3F, CF3). IR (KBr, cm1):  = 3024, 2962, 2932, 2874 (w), 1677 (s), 1641, 1610, 
1591, 1536, 1514, 1460 (w), 1427 (s), 1410, 1373 (w), 1320, 1311 (m), 1260 (w), 1206 (s), 
1173, 1160 (w), 1133 (s), 1050, 1038 (w), 1018 (m), 1005, 977 (w), 946, 899 (s), 846 (m), 823, 
802 (s), 766 (w), 752 (m), 729 (s), 703, 688, 663, 642 (m), 631 (w), 599, 569 (s), 541 (m). GC-
MS (EI, 70 eV): m/z (%) = 564 ([M]+, 43), 563 (11), 537 (11), 536 (32), 535 (100), 403 (17), 
402 (50), 401 (28), 387 (16), 386 (11), 374 (25), 373 (86). HRMS (EI, 70 eV): calcd for 
C31H23F3O5S1 [M]+: 564.12128, found 564.121848.
1,4-Bis(3,5-dimethylphenyl)-2-(trifluoromethylsulfonyloxy)anthraquinone (195e)
Starting with 193 (100 mg, 0.15 mmol), 188l (45 mg, 0.3 mmol), 
Pd(PPh3)4 (10 mg, 6 mol-%, 0.009 mmol), K3PO4 (96 mg, 0.45 mmol) 
and 1,4-dioxane (4 mL), 1195e was isolated as a yellow solid (52 mg, 
60%), mp 211-213 oC. 1H NMR (300 MHz, CDCl3):  = 2.31 (s, 6H, 
2CH3), 2.32 (s, 6H, 2CH3), 6.79 (b, 2H, ArH), 6.86 (b, 2H, ArH), 7.03 
(b, 2H, ArH), 7.44 (s, 1H, ArH), 7.61-7.64 (m, 2H, ArH), 7.96-7.99 (m, 
2H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 21.4 (2CH3), 21.4 
(2CH3), 118.1 (q, JF,C = 320.2 Hz, CF3), 125.5, 126.2, 126.9, 127.0, 129.1, 129.6, 129.8 (CH), 
132.2, 133.7, 133.7, 133.8 (C), 134.0, 134.1 (CH), 135.3, 136.8, 137.7, 137.9, 140.5, 146.7, 
149.9 (C), 182.7, 182.8 (CO). 19F NMR (282 MHz, CDCl3):  = -74.51 (s, 3F, CF3). IR (KBr, 
cm1):  = 3005, 2916, 2861 (w), 1674 (s), 1593, 1537, 1442, 1427 (w), 1405 (m), 1371 (w), 
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1331, 1294 (m), 1267 (w), 1240 (m), 1206 (s), 1173, 1162 (m), 1134, 1026, 1010 (s), 968 (m), 
920, 898, 883 (w), 848, 814, 796 (s), 771, 752 (w), 729, 723 (s), 708 (w), 692, 648, 631, 604 
(s), 570, 552, 530 (m). GC-MS (EI, 70 eV): m/z (%) = 564 ([M]+, 66), 550 (22), 549 (80), 432 
(14), 431 (49), 430 (21), 417 (34), 416 (86), 415 (36), 402 (16), 401 (57), 387 (14), 215 (14), 
208 (100), 207 (15). HRMS (EI, 70 eV): calcd for C31H23F3O5S [M]+: 564.12128, found 
564.122443.
1,2-Bis(trifluoromethylsulfonyloxy)-4-(4-methoxyphenyl)anthraquinone (196a)
Starting with 193 (100 mg, 0.15 mmol), 188b (23 mg, 0.15 mmol), 
Pd(PPh3)4 (5 mg, 3 mol-%, 0.0045 mmol), K3PO4 (48 mg, 0.225 mmol) 
and 1,4-dioxane (3 mL), 196a was isolated as a red solid (36 mg, 38%),
mp 87-88 oC.1H NMR (300 MHz, CDCl3):  =  3.82 (s, 3H, OCH3), 
6.91-6.93 (m, 1H, ArH), 6.94-6.96 (m, 1H, ArH), 7.13-7.14 (m, 1H, 
ArH), 7.16-7.18 (m, 1H, ArH), 7.59 (s, 1H, ArH), 7.69-7.78 (m, 2H, 
ArH), 7.99-8.01 (m, 1H, ArH), 8.21-8.24 (m, 1H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 
55.3 (OCH3), 114.0 (CH), 115.9 (q, JF,C = 318.4 Hz, CF3), 121.0 (q, JF,C = 320.2 Hz, CF3), 
127.2, 127.4, 129.2 (CH), 129.3 (C), 131.1 (CH), 131.2, 131.9, 132.9, 133.4 (C), 134.5, 135.0 
(CH), 138.1, 143.1, 146.2, 159.9 (C), 181.1, 181.4 (CO). 19F NMR (282 MHz, CDCl3):   = -
73.33 (q, JF = 5.33, 2.45 Hz, 3F, CF3), -72.56 (q, JF = 5.70, 2.79 Hz, 3F, CF3). IR (KBr, cm1):  
 = 2961, 2916, 2840 (w), 1680 (s), 1607, 1593, 1579, 1513 (w), 1432 (s), 1323 (m), 1303 (w), 
1243, 1204, 1177, 1168, 1126 (s), 1044, 1030 (m), 1013, 996 (s), 905 (w), 865, 830, 805, 784, 
760, 723 (s), 684, 654, 644, 622 (m), 593, 579 (s), 534 (m). GC-MS (EI, 70 eV): m/z (%) = 610 
([M+H]+, 100), 479 (10), 478 (27), 477 (82), 385 (10), 346 (12), 345 (24), 317 (28), 316 (93), 
315 (10). HRMS (EI, 70 eV): calcd for C23H12F6O9S2 [M]+: 609.98214, found 609.981630.
1,2-Bis(trifluoromethylsulfonyloxy)-4-(4-tert-butylphenyl)anthraquinone (196b)
Starting with 193 (100 mg, 0.15 mmol), 188c (27 mg, 0.15 mmol), 
Pd(PPh3)4 (5 mg, 3 mol-%, 0.0045 mmol), K3PO4 (48 mg, 0.225 mmol) 
and 1,4-dioxane (3 mL), 196b was isolated as a yellow solid (40 mg, 
41%), mp 80-81 oC. 1H NMR (300 MHz, CDCl3):  = 1.33 (s, 9H, 
3CH3), 7.13-7.17 (m, 2H, ArH), 7.41-7.44 (m, 2H, ArH), 7.60 (s, 1H, 
ArH), 7.69-7.78 (m, 2H, ArH), 7.99-8.02 (m, 1H, ArH), 8.22-8.25 (m, 
1H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 30.31 (3CH3), 33.75 (C), 115.0 (q, JF,C = 319.4 
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Hz, CF3), 120.0 (q, JF,C = 321.7 Hz, CF3), 124.5, 126.2, 126.4, 126.5 (CH), 128.2 (C), 130.2 
(CH), 131.0, 132.0, 132.4 (C), 133.5, 134.0 (CH), 135.1, 137.2, 142.1, 145.5, 150.5 (C), 180.1, 
180.3 (CO). 19F NMR (282 MHz, CDCl3):  = 73.32 (q, JF = 5.31, 2.52 Hz, 3F, CF3), -72.56 
(q, JF = 6.09, 2.97 Hz, 3F, CF3). IR (KBr, cm1):  = 2963 (m), 2870 (w), 1684 (s), 1594, 1577 
(w), 1436 (s), 1364 (w), 1325 (m), 1303 (w), 1245, 1218 (s), 1169 (w), 1135 (s), 1105, 1045, 
1018, 1000, 906 (w), 870 (m), 839 (w), 806 (m), 783, 763, 727, 703, 685, 655, 644, 624 (w), 
598 (m), 575 (w). GC-MS (EI, 70 eV): m/z (%) = 636 ([M]+, 53), 623 (12), 622 (27), 621 (90), 
581 (14), 580 (27), 579 (100), 447 (26). HRMS (EI, 70 eV): calcd for C26H18F6O8S2 [M]+: 
636.03418, found 636.033895.
1,2-Bis(trifluoromethylsulfonyloxy)-4-(4-methylphenyl)anthraquinone (196c)
Starting with 193 (100 mg, 0.15 mmol), 188e (20 mg, 0.15 mmol), 
Pd(PPh3)4 (5 mg, 3 mol-%, 0.0045 mmol), K3PO4 (48 mg, 0.225 mmol) 
and 1,4-dioxane (3 mL), 196c was isolated as a yellow solid (56 mg, 
61%), mp 79-80 oC. 1H NMR (300 MHz, CDCl3):  = 2.37 (s, 3H, 
CH3), 7.09-7.11 (m, 2H, ArH), 7.20-7.23 (m, 2H, ArH), 7.58 (s, 1H, 
ArH), 7.67-7.76 (m, 2H, ArH), 7.97-8.00 (m, 1H, ArH), 8.20-8.23 (m, 
1H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 21.36 (CH3), 113.4 (q, JF,C = 318.8 Hz, CF3),
123.6 (q, JF,C = 319.1 Hz, CF3), 127.2, 127.4, 127.6 (CH), 128.3 (C), 129.3, 131.1 (CH), 132.0, 
132.9, 133.4 (C), 134.6, 135.0 (CH), 136.2, 138.3, 138.4, 143.1, 146.5 (C), 181.1, 181.3 (CO).
19F NMR (282 MHz, CDCl3):   = -73.33 (q, JF = 5.13, 2.34 Hz, 3F, CF3), -72.58 (d, JF = 2.88 
Hz, 3F, CF3). IR (KBr, cm1):  = 3070, 3027, 2924, 2871 (w), 1680 (s), 1593, 1578, 1513 (w), 
1432 (s), 1322 (m), 1303 (w), 1243 (m), 1203 (s), 1168 (m), 1126 (s), 1044, 1021, 1015 (w), 
998 (m), 946, 905 (w), 865, 818, 805 (s), 783, 760 (m), 723 (s), 708, 684, 645, 627 (w), 593, 
576 (s), 532 (w). GC-MS (EI, 70 eV): m/z (%) = 594 ([M+H]+, 17), 579 (14), 461 (19), 369 
(10), 330 (19), 329 (32), 316 (10), 315 (45), 301 (19), 300 (31), 215 (31), 64 (100), 48 (58). 
HRMS (EI, 70 eV): calcd for C23H12F6O8S2 [M]+: 593.98723, found 593.985244.
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1,2-Bis(trifluoromethylsulfonyloxy)-4-(4-ethylphenyl)anthraquinone (196d)
Starting with 193 (100 mg, 0.15 mmol), 188f (22 mg, 0.15 mmol), 
Pd(PPh3)4 (5 mg, 3 mol-%, 0.0045 mmol), K3PO4 (48 mg, 0.225 mmol) 
and 1,4-dioxane (3 mL), 196d was isolated as an orange solid (61 mg, 
65%), mp 101-103 oC. 1H NMR (300 MHz, CDCl3):  = 1.25 (t, J  = 
7.65 Hz, CH3), 2.69 (q, J = 14.94, 7.62 Hz, 2H, CH2), 7.12-7.15 (m, 
2H, ArH), 7.24-7.26 (m, 2H, ArH), 7.59 (s, 1H, ArH), 7.68-7.77 (m, 
2H, ArH), 7.98-8.01 (m, 1H, ArH), 8.21-8.24 (m, 1H, ArH). 13C NMR (75.4 MHz, CDCl3):  = 
15.2 (CH3), 28.6 (CH2), 113.2 (q, JF,C  = 321.0 Hz, CF3), 121.7 (q, JF,C  = 321.0 Hz, CF3), 126.2, 
126.4, 126.7, 127.0 (CH), 128.2, 130.1 (C), 131.0 (CH), 131.9, 132.4 (C), 133.5, 134.0 (CH), 
135.4, 137.3, 142.1, 143.6, 145.5 (C), 180.1, 180.3 (CO). 19F NMR (282 MHz, CDCl3):  = -
73.32 (q, JF = 5.31, 2.76 Hz, 3F, CF3), -72.56 (q, JCF = 6.09, 2.94 Hz, 3F, CF3). IR (KBr, 
cm1):  = 3075, 3027, 2965, 2931, 2874 (w), 1681 (s), 1611, 1593, 1577, 1512 (w), 1433 (s), 
1323 (m), 1303 (w), 1243 (m), 1205 (s), 1168 (m), 1128 (s), 1044 (w), 1015, 998 (m), 905 (w), 
865 (s), 826 (m), 803 (s), 783, 760, 754 (m), 723 (s), 684, 654, 645, 626 (w), 594 (s), 533 (w). 
GC-MS (EI, 70 eV): m/z (%) = 608 ([M]+, 32), 581 (11), 580 (20), 579 (85), 475 (14), 447 
(14), 383 (12), 382 (12), 354 (25), 344 (13), 343 (23), 316 (18), 315 (100), 314 (36), 313 (14). 
HRMS (EI, 70 eV): calcd for C24H14F6O8S2 [M]+: 608.00288, found 608.003921.
1,2-Bis(trifluoromethylsulfonyloxy)-4-(3-trifluoromethylphenyl)anthraquinone (196e)
Starting with 193 (100 mg, 0.15 mmol), 188g (28 mg, 0.15 mmol), 
Pd(PPh3)4 (5 mg, 3 mol-%, 0.0045 mmol), K3PO4 (48 mg, 0.225 mmol) 
and 1,4-dioxane (3 mL), 196e was isolated as a yellow crystal (40 mg, 
40%), mp 169-171 oC.1H NMR (300 MHz, CDCl3):  = 7.41 (d, J =
7.71 Hz, 1H, ArH), 7.47 (b, 1H, ArH), 7.54 (d, J  = 7.80 Hz 1H, ArH), 
7.59 (s, 1H, ArH), 7.68-7.71 (m, 1H, ArH), 7.73-7.81 (m, 2H, ArH), 7.97-8.00 (m, 1H, ArH), 
8.23-8.26 (m, 1H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 117.5 (q, JF,C = 321.3 Hz, CF3),
121.2 (q, JF,C  = 272.3 Hz, CF3), 123.5 (d, J = 3.8 Hz), 124.2 (d, J = 3.7 Hz), 126.3, 126.6 
(CH), 127.3 (q, JF,C = 265.5 Hz, CF3), 128.0 (CH), 128.4 (C), 129.8 (d, J  = 5.1 Hz), 129.9, 
130,3, 131.0 (C), 131.9, 132.0, 133.9, 134.2 (CH), 138.0, 138.8, 142.4, 143.3 (C), 179.8, 179.9 
(CO). 19F NMR (282 MHz, CDCl3):  = -73.25 (q, JF = 5.78, 2.84 Hz, 3F, CF3), -72.48 (q, JF = 
5.16, 2.25 Hz, 3F, CF3), -62.59 (s, 3F, CF3). IR (KBr, cm1):  = 2954, 2923, 2852 (w), 1690 
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(m), 1676 (s), 1612, 1593, 1578, 1570, 1489 (w), 1446, 1429 (s), 1412 (m), 1389, 1334 (w), 
1306, 1242, 1208, 1180, 1163, 1118, 1049, 1071, 1046, 1007 (s), 927, 909 (w), 879, 841 (s), 
828 (m), 811, 802, 782 (s), 773 (w), 759, 741, 724, 717, 701, 680 (s), 657, 650, 624 (m), 603, 
591, 571 (s), 530 (m). GC-MS (EI, 70 eV): m/z (%) = 647 ([M]+, 17), 579 (10), 516 (15), 515 
(49), 451 (29), 424 (25), 423 (100), 395 (13), 384 (26), 383 (50), 312 (12), 355 (37), 354 (71). 
HRMS (EI, 70 eV): calcd for C23H9F9O8S2 [M]+: 647.95896, found 647.958459.
1,2-Bis(trifluoromethylsulfonyloxy)-4-(3-chlorophenyl)anthraquinone (196f)
Starting with 193 (100 mg, 0.15 mmol), 188m (23 mg, 0.15 mmol), 
Pd(PPh3)4 (5 mg, 3 mol-%, 0.0045 mmol), K3PO4 (48 mg, 0.225 mmol) 
and 1,4-dioxane (3 mL), 196f was isolated as a yellow crystal (53 mg, 
56%), mp 78-80 oC.1H NMR (300 MHz, CDCl3):  = 6.58 (dt, J = 
7.17, 1.65 Hz, 1H, ArH), 6.68-6.70 (m, 1H, ArH), 6.81-6.90 (m, 2H, 
ArH), 7.06 (s, 1H, ArH), 7.19-7.28 (m, 2H, ArH), 7.47-7.50 (m, 1H, ArH), 7.71-7.74 (m, 1H, 
ArH). 13C NMR (62.9 MHz, CDCl3):  = 114.0 (q, JF,C = 316.2 Hz, CF3), 120.0 (q, JF,C = 320.2 
Hz, CF3), 124.8, 126.3, 126.5, 126.6, 127.5 (CH), 128.3 (C), 128.8, 129.8 (CH), 130.9, 131.9, 
132.0 (C), 133.5 (CH), 133.8 (C), 134.1 (CH), 137.8, 139.8, 142.2, 143.5 (C), 179.8, 179.9 
(CO). 19F NMR (282 MHz, CDCl3):   = -73.90 (q, JF = 4.99, 2.85 Hz, 3F, CF3), -73.11 (q, JF,C 
= 5.53, 2.99 Hz, 3F, CF3). IR (KBr, cm1):  = 3070, 2961 (w), 1680 (s), 1592, 1577 (w), 1433 
(s), 1323 (m), 1303 (w), 1244, 1205 (s), 1169 (m), 1127, 1093, 1080 (s), 1045 (m), 1008, 876, 
837, 799, 784, 761, 711, 689, 654 (s), 623 (m), 593, 572 (s), 535 (m). GC-MS (EI, 70 eV): m/z
(%) = 617 ([M]+, 2x 37Cl, 07), 616 ([M+H]+, 37Cl, 32), 615 ([M]+, 37Cl, 24), 614 ([M+H]+, 35Cl, 
82), 613 ([M]+, 35Cl, 16), 579 (15), 483 (12), 482 (12), 481 (29), 446 (16), 382 (18), 355 (18), 
354 (100), 350 (12), 349 (20). HRMS (EI, 70 eV): calcd for C22H9Cl1F6O8S2 ([M]+, 35Cl): 
613.93261, found 613.932573. calcd for C22H9Cl1F6O8S2 ([M]+, 37Cl): 615.92966, found 
615.931303.
3.4.2 General Procedure for the Synthesis of 197
The reaction was carried out in a pressure tube. To a dioxane suspension (4 mL) of 193
(100 mg, 0.15 mmol), Ar1B(OH)2 (0.3 mmol) and Pd(PPh3)4 (6 mol-%) was added K3PO4 (96 
mg, 0.45 mmol), and the resultant solution was degassed by bubbling argon through the 
solution for 10 min. The mixture was heated at 95 °C under an argon atmosphere for 10 h. The 
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mixture was cooled to 20 °C. Ar2B(OH)2 (0.15 mmol), Pd(PPh3)4 (3 mol-%), K3PO4 (48 mg, 
0.225 mmol) and dioxane (2 mL) were added. The reaction mixtures were heated under an 
argon atmosphere for 10 h at 110 °C. They were diluted with H2O and extracted with CH2Cl2
(3 × 25 mL). The combined organic layers were dried (Na2SO4), filtered and the filtrate was 
concentrated in vacuo. The residue was purified by flash chromatography (flash silica gel, 
EtOAc/heptanes).
1,4-Bis(4-tert-butylphenyl)-2-(4-chlorophenyl)anthraquinone (197)
Starting with 193 (100 mg, 0.15 mmol), 188c (54 mg, 0.3 mmol), 
Pd(PPh3)4 (17 mg, 10 mol-%, 0.015 mmol), K3PO4 (143 mg, 
0.675 mmol) and 1,4-dioxane (5 mL), and 188d (23 mg, 0.15
mmol), 197 was isolated as a yellow solid (40 mg, 45%), mp 288-
290 oC. 1H NMR (300 MHz, CDCl3):  = 1.25 (s, 9H, 3CH3), 
1.32 (s, 9H, 3CH3), 6.80-6.83 (m, 2H, ArH), 6.84-6.88 (m, 2H, 
ArH), 6.98-7.01 (m, 2H, ArH), 7.17-7.24 (m, 4H, ArH), 7.39-
7.41 (m, 2H, ArH), 7.48 (s, 1H, ArH), 7.58-7.62 (m, 2H, ArH), 
7.94-8.01 (m, 2H, ArH). 13C NMR (62.9 MHz, CDCl3):  = 31.3 (3CH3), 31.4 (3CH3), 34.5, 
34.6 (C), 124.7, 125.1, 126.6, 126.8, 127.6, 127.8 (CH), 128.2 (C), 128.9, 130.7 (CH), 131.8, 
133.1 (C), 133.5, 133.6 (CH), 133.9, 134.4, 136.5, 138.2 (C), 138.6 (CH), 139.0, 141.7, 143.8, 
146.5, 149.5, 150.0 (C), 183.9, 184.5 (CO). IR (KBr, cm1):  = 3076, 3025 (w), 2958 (m), 
2902, 2865 (w), 1677 (s), 1591 (m), 1523, 1512, 1490, 1471, 1462, 1443, 1423, 1400, 1358 
(w), 1329, 1306, 1269, 1248, 1217 (m), 1158, 1137, 1115 (w), 1092 (m), 1039 (w), 1013  (m), 
964, 946, 935, 915, 899, 863, 846, 836 (w), 822 (s), 800 (m), 768, 746 (w), 730 (s), 721 (m), 
697, 669, 658, 647, 631, 621, 608 (w), 575, 568 (m), 531 (w). GC-MS (EI, 70 eV): m/z (%) = 
585 ([M+H]+, 37Cl, 08), 584 ([M]+, 37Cl, 22), 583 ([M+H]+, 35Cl, 22), 582 ([M]+, 35Cl, 46), 581 
(10), 570 (15), 569 (30), 568 (40), 567 (63), 566 (10), 565 (10), 528 (20), 527 (44), 526 (56), 
525 (100), 524 (11), 513 (10), 512 (23), 511 (27), 510 (43). HRMS (EI, 70 eV): calcd for 
C40H35Cl1O2 [M]+: 582.23201, found 582.231833.
3.5 Synthesis of Dimethyl 3,5-dihydroxyphthalate (200)
To a solution of Diene 198 (1 equiv) in toluene (0.5 mL/mmol) was added to DMAD 
199 (1.5 equiv) at -78 °C. The mixture was allowed to warm to 50 °C during 48 h with stirring. 
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To the mixture were added hydrochloric acid (10%) and dichloromethane (10 mL/2 mmol). 
The organic and the aqueous layer were separated and the latter was extracted with CH2Cl2. 
The combined organic layers were dried (Na2SO4), filtered and the filtrate was concentrated in 
vacuo. The residue was purified by column chromatography (flash silica gel, heptanes/EtOAc).
Dimethyl 3,5-dihydroxyphthalate (200)
Starting with 198 (5.0 g, 19.19 mmol), Toluene (5 mL), 199 (4.1g, 3.5 mL, 
43.2 mmol), 200 was isolated as colorless solid (1.45 g, 33%), mp 127-129 
oC. 1H-NMR (300 MHz, CDCl3):  = 3.80 (s, 3H, OCH3), 3.81 (s, 3H, 
OCH3), 6.34 (d, J = 2.35 Hz, 1H, ArH), 6.40 (d, J = 2.35 Hz, 1H, ArH), 
6.95 (s, 1H, OH), 10.89 (s, 1H, OH). 13C-NMR (62.9 MHz, CDCl3):  = 52.6 (OCH3), 53.0 
(OCH3), 102.6 (C), 104.8, 108.1 (CH), 137.1, 161.4, 163.6 (C), 169.0, 170.2 (CO). IR (KBr, 
cm1):  = 3201 (m), 3074, 3007, 2954, 2851 (w), 1726 (w), 1690 (m), 1667, 1621 (s), 1586 
(m), 1567, 1536, 1515 (w), 1493 (m), 1435 (s), 1383, 1337 (m), 1302, 1238, 1195, 1182, 1165 
(s), 1108, 1024, 994, 948, 917, 865, 855, 850 (m), 833 (w), 799, 782 (m), 724, 703 (s), 643, 
615, 578, 543 (m). GC-MS (EI, 70 eV): m/z (%) = 226 ([M]+ 34), 195 (46), 194 (42), 164 (14), 
137 (12), 136 (100), 135 (17). HRMS (EI, 70 eV): calcd for C10H10O6 [M+]: 226.04719, found 
226.046991. 
3.5.1 Synthesis of Dimethyl 3,5-bis(trifluoromethylsulfonyloxy)phthalate (201)
To a solution of 200 (1.0 equiv) in CH2Cl2 (10 mL/mmol) was added pyridine (4.0 
equiv) at room temperature under an argon atmosphere. After 10 min, Tf2O (2.4 equiv) was 
added at -78 °C. The mixture was allowed to warm up to room temperature and stirred for 
overnight. The reaction mixture was filtered and the filtrate was concentrated in vacuo. The 
products of the reaction mixture were isolated by rapid column chromatography (flash silica 
gel, heptanes/EtOAc). 
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Dimethyl 3,5-bis(trifluoromethylsulfonyloxy)phthalate (201)
Starting with 200 (1.76 g, 7.8 mmol), pyridine (2.5 mL, 31.2 mmol), 
CH2Cl2 (80 mL), Tf2O (3.15 mL, 18.74 mmol), 201 was isolated as viscous 
red oil (3.00 g, 78%). 1H-NMR (300 MHz, CDCl3):  = 3.87 (s, 3H, OCH3), 
3.93 (s, 3H, OCH3), 7.43 (d, J = 2.34 Hz, 1H, ArH), 7.86 (d, J = 2.34 Hz, 
1H, ArH). 13C-NMR (62.9 MHz, CDCl3):  = 53.5 (OCH3), 53.6 (OCH3), 118.3 (q, JF,C = 
320.6 Hz, CF3), 118.6 (q, JF,C = 321.1 Hz, CF3), 119.2, 122.8 (CH), 129.3, 132.3, 146.4, 149.2 
(C), 162.7, 163.2 (CO). 19F NMR (282 MHz, CDCl3):  = -72.25 (d, JF = 2.34 Hz, 3F, CF3), -
73.23 (d, JF = 2.25 Hz, 3F, CF3). IR (KBr, cm1):  = 3102, 3011, 2960, 2904, 2848 (w), 1737 
(s), 1610, 1587, 1476 (w), 1428, 1298, 1245, 1205, 1125 (s), 1082, 1002 (m), 980 (s), 954, 913 
(m), 878 (w), 841 (m), 818, 791 (s), 772 (w), 755 (s), 743 (m), 700, 676, 639 (w), 597 (s). GC-
MS (EI, 70 eV): m/z (%) = 490 ([M+H]+ 07), 461 (11), 460 (14), 459 (100), 395 (11), 268 (14).
HRMS (EI, 70 eV): calcd for C12H8F6O10S2 [M]+: 489.94576, found 489.945970.
3.5.2 General Procedure for Suzuki-Miyaura Reactions
A 1,4-dioxane solution (4 mL per 3 mmol of 201) of 201, K2CO3, Pd(PPh3)4 and 
arylboronic acid 188 was stirred at 110 °C or 90 °C for 10 h. After cooling to 20 °C, distilled 
water was added. The organic and the aqueous layers were separated and the latter was 
extracted with CH2Cl2. The combined organic layers were dried (Na2SO4), filtered and the 
filtrate was concentrated in vacuo. The residue was purified by column chromatography.
Dimethyl 3,5-bis(4-tert-butylphenyl)phthalate (202a)
Starting with 201 (200 mg, 0.40 mmol), 188c (171 
mg,  0.96 mmol), Pd(PPh3)4 (28 mg, 6 mol%, 0.024
mmol), K3PO4 (255 mg, 1.2 mmol) and 1,4-dioxane 
4 mL), 202a was isolated as colorless oil (171 mg, 
91%). 1H-NMR (300 MHz, CDCl3):  = 1.24 (s, 
18H, 6CH3), 3.60 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 7.24-7.66 (m, 8H, ArH), 8.10 (s, 1H, 
ArH), 8.11 (s, 1H, ArH). 13C-NMR (62.9 MHz, CDCl3):  = 30.2, 30.2 (6CH3), 33.5, 33.5 
(2C), 51.2, 51.5 (OCH3), 124.2, 124.8, 125.8, 126.0, 127.2 (CH), 127.6 (C), 131.5 (CH), 132.0, 
135.1, 135.3, 140.0, 140.9, 149.7, 150.3 (C), 165.2, 168.4 (CO). IR (KBr, cm1):  = 3030 (w), 
2951, 2903, 2867 (m), 2255, 1911 (w), 1726 (s), 1600, 1514, 1460 (w), 1431 (m), 1393, 1362 
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(w), 1343 (m), 1264, 1242, 1199 (s), 1176 (m), 1122, 1067 (s), 1056 (m), 1016, 976, 963 (w), 
906 (m), 874, 854 (w), 832 (s), 805 (w), 793 (m), 775 (w), 729 (s), 707 (m), 696, 647, 625 (w), 
589, 555 (m). GC-MS (EI, 70 eV): m/z (%) = 458 ([M]+, 44), 444 (31), 443 (100), 214 (10).
HRMS (EI, 70 eV): calcd for C30H34O4 [M]+: 458.24516, found 458.244023.
Dimethyl 3,5-bis(4-chlorophenyl)phthalate (202b)
Starting with 201 (200 mg, 0.40 mmol), 188d (150 mg,  0.96
mmol), Pd(PPh3)4 (28 mg, 6 mol%, 0.024 mmol), K3PO4 (255 
mg, 1.2 mmol) and 1,4-dioxane (4 mL), 202b was isolated as 
colorless oil (150 mg, 88%). 1H-NMR (300 MHz, CDCl3):  = 
3.62 (s, 3H, OCH3), 3.84 (s, 3H, OCH3), 7.26-7.36 (m, 6H, 
ArH), 7.44-7.47 (m, 2H, ArH), 7.57 (d, J = 1.86 Hz, 1H, ArH), 8.09 (d, J = 1.86 Hz, 1H, ArH).
13C-NMR (62.9 MHz, CDCl3):  = 52.5 (OCH3), 52.7 (OCH3), 127.5, 128.4, 128.6 (CH), 129.1 
(C), 129.2, 129.9, 132.2 (CH), 133.6, 134.3, 134.6, 137.3, 137.5, 140.1, 141.1 (C), 165.8, 168.8
(CO). IR (KBr, cm1):  = 3067, 3030, 2997, 2949, 2840 (w), 1723 (s), 1601 (w), 1494 (m), 
1458 (w), 1430 (m), 1398, 1380 (w), 1341 (m), 1269, 1241 (s), 1199, 1175 (m), 1119, 1090, 
1066 (s), 1054 (m), 1012 (s), 973, 960, 904, 872, 845 (w), 825 (s), 806 (w), 792 (m), 772 (w), 
755 (m), 729 (s), 705, 692, 646, 633, 618, 566 (w). GC-MS (EI, 70 eV): m/z (%) = 418 ([M]+,
2x 37Cl, 07), 417 ([M+H]+, 37Cl, 09), 416 ([M]+, 37Cl, 40), 415 ([M+H]+, 35Cl, 14), 414 ([M]+, 
35Cl, 60), 387 (12), 386 (14), 385 (67), 384 (23), 383 (100), 226 (15). HRMS (EI, 70 eV): calcd 
for C22H16Cl2O4 ([M]+, 35Cl): 414,04202, found 414.041035.
Dimethyl 3-(trifluoromethylsulfonyloxy)-5-(4-triflouromethylphenyl)phthalate (203a)
Starting with 201 (200 mg, 0.40 mmol), 188a (76 mg,  0.40 mmol), 
Pd(PPh3)4 (18 mg, 4 mol%, 0.016 mmol), K3PO4 (127 mg, 0.6 
mmol) and 1,4-dioxane (3 mL), 203a was isolated as colorless solid 
(152 mg, 76%), mp 103-104 oC. 1H-NMR (300 MHz, CDCl3):  = 
3.88 (s, 3H, OCH3), 3.92 (s, 3H, OCH3), 7.61-7.68 (m, 4H, ArH), 
7.72 (d, J = 1.56 Hz, 1H, ArH), 8.14 (d, J = 1.56 Hz, 1H, ArH). 13C-NMR (62.9 MHz, CDCl3): 
 = 53.2, 53.3 (OCH3), 118.4 (q, JF,C = 320.5 Hz, CF3), 122.0 (C), 123.8 (CH), 125.6 (C), 
126.3 (d, J = 3.76 Hz), 127 (CH), 128.2 (C), 128.3 (CH), 131.5, 140.8, 143.3, 146.5 (C), 164.3, 
164.4 (CO). 19F NMR (282 MHz, CDCl3):  = -73.46 (s, 3F, CF3), -62.77 (s, 3F, CF3). IR 
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(KBr, cm1):  = 3088, 3009, 2956, 2923, 2815 (w), 1738 (m), 1728 (s), 1613, 1562, 1481 (w), 
1427 (s), 1394 (w), 1324, 1292 (s), 1260 (w), 1246  (m), 1206, 1163, 1142, 1115, 1098, 1069, 
1055 (s), 1016 (m), 992 (s), 952 (w), 920 (m), 897, 870 (w), 842 (m), 823, 804, 791 (s), 772 
(m), 758 (s), 742 (m), 671, 663, 637 (w), 599 (s), 568 (w). GC-MS (EI, 70 eV): m/z (%) = 486
([M]+, 43), 456 (17), 455 (100), 264 (830), 263 (12). HRMS (EI, 70 eV): calcd for 
C18H12F6O7S1 [M+]: 486.02024, found 486.020205.
Dimethyl 3-(trifluoromethylsulfonyloxy)-5-(4-tert-butylphenyl)phthalate (203b)
Starting with 201 (200 mg, 0.40 mmol), 188c (71 mg,  0.40
mmol), Pd(PPh3)4 (18 mg, 4 mol%, 0.016 mmol), K3PO4 (127 
mg, 0.6 mmol) and 1,4-dioxane (3 mL), 203b was isolated as 
colorless oil (139 mg, 71%). 1H-NMR (300 MHz, CDCl3):  = 
1.28 (s, 9H, 3CH3), 3.86 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 
7.45 (s, 4H, ArH), 7.62 (d, J = 1.62 Hz, 1H, ArH), 8.11 (d, J = 1.62 Hz, 1H, ArH). 13C-NMR 
(62.9 MHz, CDCl3):  = 31.2 (3CH3), 34.7 (C), 53.0, 53.1 (OCH3), 118.5 (q, JF,C = 320.3 Hz, 
CF3), 123.2, 126.2 (CH), 126.8 (C), 126.9, 127.9 (CH), 131.2, 134.4, 144.8, 146.5, 152.6 (C), 
165.8, 168.8 (CO). 19F NMR (282 MHz, CDCl3):  = -73.57 (s, 3F, CF3). IR (KBr, cm1):  = 
3033 (w), 2955 (m), 2906, 2870 (w), 1731 (s), 1612 (m), 1573, 1553, 1521, 1479 (w), 1425 (s), 
1318 (m), 1267, 1245, 1206, 1156, 1135, 1115 (s), 1093, 1057 (m), 997 (s), 959 (w), 925 (s), 
890, 872 (w), 834 (m), 820, 804, 789 (s), 765, 749 (m), 704, 664, 640 (w), 602 (s), 571, 551 
(m). GC-MS (EI, 70 eV): m/z (%) = 474 ([M]+, 23), 460 (22), 459 (100). HRMS (EI, 70 eV): 
calcd for C21H21F3O7S1 [M+]: 474.09546, found 474.095709.
3.6 Synthesis of 5,7-Dibromo-8-(trifluoromethylsulfonyloxy)quinoline (205)
To a solution of 204 (1.0 equiv) in CH2Cl2 (10 mL/mmol) was added pyridine (7.0 
equiv) at room temperature under an argon atmosphere. After 10 min, Tf2O (5.0 equiv) was 
added at -78 °C. The mixture was allowed to warm up to room temperature and stirred for 
overnight. The reaction mixture was filtered and the filtrate was concentrated in vacuo. The 
products of the reaction mixture were isolated by rapid column chromatography (flash silica 
gel, heptanes/EtOAc).
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5,7-Dibromo-8-(trifluoromethylsulfonyloxy)quinoline (205)
Starting with 204 (1.00 g, 3.30 mmol), pyridine (0.7 mL, 8.25 mmol), CH2Cl2
(40 mL), Tf2O (0,7 mL, 3.96 mmol), 205 was isolated as colorless solid (1.15 
g, 80%), mp 119-120 oC. 1H-NMR (300 MHz, CDCl3):  = 7.54 (dd, J = 
8.61, 4.23 Hz, 1H, ArH), 8.00 (s, 1H, ArH), 8.44 (dd, J = 8.58, 7.05 Hz, 1H, 
ArH), 8.97 (dd, J = 4.23, 2.67 Hz, 1H, ArH). 13C-NMR (62.9 MHz, CDCl3):  = 117.6 (d, JF,C
= 320.9 Hz, CF3), 114.9, 120.5 (C), 122.6 (CH), 126.8 (C), 132.3, 134.7 (CH), 140.8, 143.0 
(C), 151 (CH). 19F NMR (282 MHz, CDCl3):  = -72.36 (s, 3F, CF3). IR (KBr, cm1):  = 3084, 
2961, 2919, 2850, 1599, 1584, 1555, 1472, 1449 (w), 1420, 1405 (m), 1347, 1334, 1291, 1249 
(w), 1229 (m), 1202, 1179, 1129, 1057 (s), 1035, 962, 933 (w), 873 (m), 825, 809, 784 (s), 765 
(m), 692 (s), 641 (m), 609, 601, 584 (s), 584, 553, 546 (m). GC-MS (EI, 70 eV): m/z (%) = 435 
([M+H]+, 81Br, 26), 433 ([M+H]+, 79Br, 13), 304 (49), 303 (10), 302 (100), 276 (37), 275 (07), 
274 (73), 272 (39). HRMS (EI, 70 eV): calcd for C10H5Br2F3N1O3S1 ([M+H]+, 79Br): 433.8304, 
found 433.8299, calcd for C10H5Br2F3N1O3S1 ([M+H]+, 81Br): 435.8283, 435.8283.
3.6.1 General Procedure for Suzuki–Miyaura Reactions
A 1,4-dioxane solution (4 mL per 3 mmol of 205) of 205, K2CO3, Pd(PPh3)4 and 
arylboronic acid 188 was stirred at 110 °C or 90 °C for 10 h. After cooling to 20 °C, distilled 
water was added. The organic and the aqueous layers were separated and the latter was 
extracted with CH2Cl2. The combined organic layers were dried (Na2SO4), filtered and the 
filtrate was concentrated in vacuo. The residue was purified by column chromatography.
5,7-Bis(4-tert-butylphenyl)-8-(trifluoromethylsulfonyloxy)quinoline (206)
Starting with 205 (100 mg, 0.22 mmol), 188c (78 mg,  0.44
mmol), Pd(PPh3)4 (15 mg, 6 mol%, 0.0132 mmol), K2CO3 (2 
mL), and 1,4-dioxane (3 mL), 206 was isolated as colorless solid 
(101 mg, 81%), mp 150-152 oC. 1H-NMR (300 MHz, CDCl3): 
= 1.30 (s, 9H, 3CH3), 1.33 (s, 9H, 3CH3), 7.33-7.36 (m, 2H, 
ArH), 7.40 (dd, J = 8.61, 4.23 Hz, 1H, ArH), 7.45-7.48 (m, 6H, 
ArH), 7.54 (s, 1H, ArH), 8.24 (dd, J = 8.55, 7.11 Hz, 1H, ArH),
8.99 (dd, J = 4.05, 2.67 Hz, 1H, ArH). 13C-NMR (62.9 MHz, CDCl3):  = 31.2, 31.35 (6CH3), 
34.7 (C), 118.5 (q, JF,C = 320.5 Hz, CF3), 121.9, 125.4, 125.6 (CH), 126.9 (C), 129.3, 129.6 
N
Br
Br
OTf
N
OTf
C(CH3)3
(H3C)3C
Experimental Section 
Page | 102
(CH), 132.3 (C), 134.0, 134.5 (CH), 134.8, 135.0, 140.3, 141.7, 142.1 (C), 151.0 (CH), 151.3, 
151.9 (C). 19F NMR (282 MHz, CDCl3):  = -75.06 (s, 3F, CF3). IR (KBr, cm1):  = 3037 (w), 
2952, 2924, 2903, 2866 (m), 1619, 1596, 1568, 1555, 1513, 1485, 1454 (w), 1416 (s), 1392 
(m), 1363, 1342, 1311, 1266, 1241 (w), 1220, 1203 (s), 1170, 1153 (m), 1135 (s), 1106, 1097, 
1065 (w), 1043, 1034, 1021, 1014 (m), 968, 940, 922, 900, 880 (w), 849 (m), 838, 828, 793 (s), 
774, 763, 755, 747, 723, 706, 687, 665, 642, 631 (w), 607, 597 (s), 577, 563, 555, 540, 529 
(w). GC-MS (EI, 70 eV): m/z (%) = 541 ([M]+, 04), 353 (22), 352 (100), 336 (14). HRMS (EI, 
70 eV): calcd for C30H30F3N1O3S1 [M]+: 541.18930, found 541.188400.
5-(4-tert-Butylphenyl)-7-bromo-8-(trifluoromethylsulfonyloxy)quinoline (207)
Starting with 205 (100 mg, 0.22 mmol), 188c (39 mg,  0.22 mmol), Pd(PPh3)4
(8 mg, 3 mol%, 0.0066 mmol), K2CO3 (1 mL), and 1,4-dioxane (2 mL), 207
was isolated as colorless solid (85 mg, 75%), mp 111-113 oC. 1H-NMR (300 
MHz, CDCl3):  = 1.33 (s, 9H, 3CH3), 7.28-7.32 (m, 2H, ArH), 7.41 (dd, J = 
8.64, 4.17 Hz, 1H, ArH), 7.45-7-50 (m, 2H, ArH), 7.65 (s, 1H, ArH), 8.20 
(dd, J = 8.61, 6.99 Hz, 1H, ArH), 8.95 (dd, J = 4.17, 2.58 Hz, 1H, ArH). 13C-
NMR (62.9 MHz, CDCl3):  = 30.31 (3CH3), 33.75 (C), 114.4 (q, JF,C = 320.5 Hz, CF3), 121.3, 
124.7 (CH), 126.0 (C), 128.5, 129.6 (CH), 132.8 (C), 133.8 (CH), 140.3, 140.8, 142.3 (C), 
150.3 (CH), 150.8, 151.2 (C). 19F NMR (282 MHz, CDCl3):  = -72.49 (s, 3F, CF3). IR (KBr, 
cm1):  = 2956 (m), 2922 (s), 2852 (m), 1743, 1728, 1693, 1665, 1630, 1602, 1589, 1515 (w), 
1462, 1451 (m), 1426 (s), 139, 1376, 1307, 1261 (w), 1241 (m), 1209 (s), 1183 (m), 1136 (s), 
1103 (w), 1055 (s), 1034 (w), 1019, 942, 881, 865 (w), 832 (s), 788, 766, 754, 746, 720, 697, 
684, 644, 619, 613 (w), 599 (s), 565, 541 (w). HRMS (EI, 70 eV): calcd for C20H18BrF3N1O3S1
([M+H]+, 79Br): 488.0137, found 488.0145, calcd for C20H18BrF3N1O3S1 ([M+H]+, 81Br): 
490.0118, found 490.0129. 
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Crystal Data and Structure Refinement for Compound 189c
Identification code                     is_a14
Empirical formula C34H32O2
Formula weight 472.60
Temperature 173 (2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group (H.-M.) P-1
Space group (Hall) -P1
Unit cell dimensions a = 9.106 (6) Å
b = 10.813 (6) Å
c = 14.071 (8) Å
	105.943 (11)°
	93.339 (13)°
	97.190 (16)°
Volume 1315.4 (13) Å3
Z 2
Density (calculated) 1.193 Mg m3
Absorption coefficient 0.07 mm1
F(000) 504
Crystal size 0.74 × 0.57 × 0.37 mm
 range for data collection  = 6.4-59.9°
Index ranges -1111,-14!14, -1818
Reflections collected 23152
Independent reflections 5994 [R(int) = 0.037]
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Completeness to  = 29.82° 99.2%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.978 and 0.948
Refinement method Full-matrix least-squares on F2
Data/ restraints / parameters 5175/0/331
Goodness-of-fit on F2 1.097    

}{ R1 = 0.0555, wR2 = 0.1476
R indices (all data) R1 =0.0482, wR2 = 0.1398
Largest diff. peak and hole 0.336 and -0.294 e Å3
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Crystal Data and Structure Refinement for Compound 190b
Identification code                     is_a17
Empirical formula C22H13F3O6S
Formula weight 462.38
Temperature 173 (2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group (H.-M.) P-1
Space group (Hall) -P 1
Unit cell dimensions a = 10.2281 (4) Å
b = 10.8657 (4) Å
c = 19.2816 (7) Å
	85.020 (2)°
	87.467 (2)°
	67.002 (2)°
Volume 1964.98 (13) Å3
Z 4
Density (calculated) 1.563 Mg m3
Absorption coefficient 0.23 mm1
F(000) 944
Crystal size 0.60 × 0.35 × 0.08 mm3
 range for data collection  = 4.7-60.5°
Index ranges -14h-14, -15k-14, -2027
Reflections collected 42358
Independent reflections 11784 [R(int) = 0.025]
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Completeness to  = 29.82° 98.6%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.982 and 0.873
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5175/0/579
Goodness-of-fit on F2 1.064        

}{ R1 = 0.0598, wR2 = 0.1145
R indices (all data) R1 = 0.0412, wR2 = 0.1067
Largest diff. peak and hole 0.39 and -0.36 e Å3
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Crystal Data and Structure Refinement for Compound 191a
Identification code                     is_a24
Empirical formula C31H23F3O2
Formula weight 484.49
Temperature 173(2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group (H.-M.)
P-1-
Space group (Hall) -P 1
Unit cell dimensions a = 9.0823 (18) Å
b = 11.869 (2) Å
c = 12.460 (3) Å
	76.95 (3)°
	88.73 (3)°
	73.54 (3)°
Volume 1253.6 (4) Å3
Z 2
Density (calculated) 1.284 Mg m3
Absorption coefficient 0.09 mm1
F(000) 504
Crystal size 0.38 × 0.37 × 0.07 mm
 range for data collection 	4.7-55.4°
Index ranges -1111, -14!15, -1616
Reflections collected 21238
Independent reflections 5706 [R(int) = 0.0245]
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Completeness to  = 29.82° 98.9%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.993 and 0.965
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 3766/0/87
Goodness-of-fit on F2 1.093

}{ R1 = 0.0860, wR2 = 0.1480
R indices (all data) R1 = 0.0499, wR2 = 0.1332
Largest diff. peak and hole 0.31 and -0.21 e Å3
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Crystal Data and Structure Refinement for Compound 195a
Identification code                     is_a136
Empirical formula C29H13F9O5S
Formula weight 651.78
Temperature 173 (2) K
Wavelength 0.71073 Å
Crystal system Monoclinic
Space group (H.-M.) P 21/n
Space group (Hall) -P 2yn
Unit cell dimensions a = 14.4439 (7) Å
b = 11.2736 (5) Å
c = 33.9566 (16) Å
	<^<<
	<^{
	<^<<
Volume 5410.3 (4) Å3
Z 8
Density (calculated) 1.600 Mg m3
Absorption coefficient 0.239 mm1
F(000) 2621
Crystal size 0.60 × 0.17 × 0.09 mm3
 range for data collection  = 1.91-24.98°
Index ranges -1717, -13!13, -4040
Reflections collected 39066
Independent reflections 9445 [R(int) = 0.0495]
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Completeness to  = 29.82° 99.4%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.9788 and 0.8698
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 6265/7/846
Goodness-of-fit on F2 1.049

}{ R1 = 0.0934, wR2 = 0.1228
R indices (all data) R1 =0.0517, wR2 = 0.1228
Largest diff. peak and hole 0.380 and -0.395 e Å3
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Crystal Data and Structure Refinement for Compound 196e
Identification code                     is_a106
Empirical formula C23H9F9O8S2
Formula weight 648.42
Temperature 173 (2) K
Wavelength 0.71073 Å
Crystal system Triclinic
Space group (H.-M.) P -1
Space group (Hall) -P 1
Unit cell dimensions a = 8.5921 (2) Å
b = 11.1466 (3) Å
c = 13.0127 (3) Å
	79.2310 (10)°
	80.2880 (10)°
	85.0560 (10)°
Volume 1204.84 (5) Å3
Z 2
Density (calculated) 1.787 Mg m3
Absorption coefficient 0.342 mm1
F(000) 648
Crystal size 0.34 × 0.18 × 0.14 mm3
 range for data collection  = 2.24-30.00°
Index ranges -155, -12!12, -1618
Reflections collected 26483
Independent reflections 6942 [R(int) = 0.0279]
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Completeness to  = 29.82° 98.7%
Absorption correction Semi-empirical from equivalents
Max. and min. transmission 0.9537 and 0.8927
Refinement method Full-matrix least-squares on F2
Data / restraints / parameters 5429/0/462
Goodness-of-fit on F2 1.027

}{ R1 = 0.0655, wR2 = 0.1174
R indices (all data) R1 = 0.0469, wR2 = 0.1079
Largest diff. peak and hole 0.587 and -0.476 e Å3
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